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9General introduction
thE hiStoRy of CoMPlEX REgional Pain SyndRoME (CRPS)
Sudeck was one of the first to describe complex regional pain syndrome (CRPS), in 1900 (1). 
One of his students called the clinical picture Sudeck’s atrophy and integrated a classifica-
tion of it that described five forms of the disease: 1) nutritional atrophy, 2) disuse atrophy, 
3) senile atrophy, 4) acute inflammatory reflex atrophy and 5) neuropathic atrophy (2). 
The next (and most-used) term for this disease became reflex sympathetic dystrophy (RSD) 
which was introduced in 1946 by Evans after he successfully treated several patients with 
pain using sympathetic blocks (3). Eventually, after a consensus meeting in 1993, the term 
complex regional pain syndrome (CRPS) replaced the concept of RSD and is now in general 
use (4). CRPS can be divided into two subtypes: i.e., CRPS type I for cases in which no nerve 
injury is detected and CRPS type II for cases in which nerve injury is confirmed. CRPS types 
I and II do not differ in clinical presentation. CRPS manifests itself often after fractures, 
sprains, contusions and/or crush injuries and exceeds, in both intensity and duration, the 
expected course of the original trauma (5). The diagnosis is even now purely based on the 
signs and symptoms, since there are no standard laboratory or imaging tests (6). Through 
the years, several diagnostic criteria sets have been formulated and used to diagnose 
CRPS: i.e., the Veldman criteria, the ‘old IASP (International Association for the Study of 
Pain) criteria’, the Bruehl and Harden criteria and the currently used Budapest criteria, 
which were accepted by the Committee for Classification of Chronic Pain of the IASP in 
2012 as the ‘new IASP diagnostic criteria for CRPS’ (7-10). Since 1994, the IASP divides pain 
mechanisms into nociceptive and neuropathic pain. In 2011, the definition neuropathic 
changed from ‘pain due to lesion or dysfunction of the nervous system’ to ‘pain caused 
by a lesion or disease of the somatosensory nervous system’. This change made it difficult 
to categorise CRPS patients, so in 2017 the IASP introduced a new mechanistic descriptor 
for ‘pain characterized by evidence of altered nociceptive processing’, such as CRPS. This 
new term is nociplastic pain, to reflect changes in function of nociceptive pathways (11).
PathoPhySiology
The exact pathophysiology of CRPS remains unknown, but there are several ideas about 
mechanisms proposed to play a role (12). Although spontaneous development is de-
scribed, tissue damage typically seems to be the initial trigger for development of CRPS. 
It is a condition affecting the extremities and has a presentation during the acute phase 
with oedema, erythema, increase in temperature, impaired function and pain as a result 
of an inflammatory response to the initiating trauma (13, 14). Alternatively, neurogenic 
inflammation can also explain the presentation with oedema, erythema and increased 
sweating (15). Another mechanism that has been described is deep-tissue microvascular 
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ischaemia-reperfusion injury, which proposes that this injury is the cause of the abnormal 
pain sensations patients describe and experience in CRPS, such as allodynia (16). Further-
more, a decrease in sweat glands and vascular innervation combined with a decrease in 
epidermal nerve fibres caused by neuropeptides, could explain the trophic and vasomotor 
symptoms of CRPS (13). Physicians claim that CRPS patients have a specific, or even a 
special way of presenting themselves. This could imply a psychological factor in the 
development of CRPS. Several studies have failed to confirm this, but some evidence has 
been found of a role for stress, depression or anxiety in the maintenance of CRPS (17). In 
a prospective study, the researchers concluded that there is no association between psy-
chological factors and the development of CRPS. In addition, it appears that psychological 
problems of CRPS patients are comparable to those of the normal population, and thus 
psychological changes may be a result of the chronic pain and disability (18). It is widely 
accepted that early diagnosis and multidisciplinary treatment are needed to prevent 
permanent disability (19). Patients diagnosed with CRPS are treated in the Netherlands 
according to the Dutch CRPS treatment guidelines (last updated in 2014) (20). Previous 
research suggests possible subtypes, phenotypes and/or stages of the syndrome, which 
can influence the outcome of the chosen therapy (4, 21). This may suggest the strategy for 
CRPS treatment should be changed to therapy based on the underlying mechanism (22).
nEuRoStiMulation
Spinal cord stimulation (SCS) is a proven, effective treatment for CRPS pain, and is a direct 
clinical application of the gate theory by Melzack and Wall. In 1965, they described a new 
theory concerning pain, based on a thesis by Noordenbosch. Thin- (pain) and large-diame-
ter (touch, pressure) nerve fibres carry information from the site of the injury to the dorsal 
horn of the spinal cord. From that point transmission cells carry the pain signal up to the 
brain, resulting in a painful sensation for the patient. Activation of A-beta nerve fibres, 
which do not transmit pain signals, can inhibit pain by interfering with these pain signals. 
This is a simplified model of a probably much more complex reality (23). In 1965, Shealy 
et al. were the first ones to introduce SCS to reduce pain by activating these A-beta nerve 
fibres (24, 25). SCS is a common treatment internationally for CRPS when other therapies 
fail to provide relief. In 2000, a study by Kemler et al. described the results of treatment 
with SCS stimulation combined with physical therapy versus physical therapy alone for 
patients with CRPS. A total of 36 patients received test stimulation, of whom 24 received a 
definitive implantation of SCS, versus 18 patients who received only physical therapy. At 
6 months follow-up, a statistically significant difference (P < 0.001) was found for the pain 
score on a visual-analogue scale in favour of the patients who received SCS combined with 
physical therapy (26). At 2-year follow-up, a clinically significant decrease in pain intensity 
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was found (P < 0.001), and patients stated that they were ‘much improved’, based on the 
global perceived effect scale (27). The same group published a 5-year follow-up in 2008 
which revealed a diminished effect on pain relief over the years, but still 95% of the pa-
tients would undergo the treatment again if necessary (28). This is an interesting finding, 
but the criteria they used at baseline to diagnose CRPS were not completely in accord with 
the new IASP diagnostic criteria for CRPS, and some patients diagnosed with CRPS back 
in 2000 would probably not receive the diagnosis today. Also, CRPS is a dynamic disease 
that changes over time and has a natural course. Thus, the diminishing effect of SCS could 
be related to the change of the disease. A new neurostimulation system to treat chronic 
pain by stimulating the dorsal root ganglion (DRG) has been used commercially since 
2012. The organisation of the DRG at each level of the spinal cord offers the possibility 
of stimulating specific dermatomes. SCS stimulation is more broadly applied, which can 
result in stimulation of an area much larger than the painful area (29). Van Buyten et al. 
used DRG stimulation in a group of 8 CRPS patients who experienced some degree of pain 
relief, persistent at 12-month follow-up. The researchers concluded DRG stimulation to be 
a promising option as a treatment for CRPS (30). The ACCURATE study, published in 2017, 
evaluated the efficacy of DRG stimulation compared to SCS for patients diagnosed with 
CRPS or causalgia (pain following peripheral nerve injury (31)) of the lower extremities. A 
total of 152 patients were included at baseline and received either DRG stimulation or SCS 
implantation after a successful trial phase. After 3 months of follow-up, the treatment suc-
cess (≥50% pain relief compared to baseline) was greater in the group who received DRG 
stimulation (81.2%) than the SCS group (55.7%). Furthermore, at 12-month follow-up, the 
pain remained significantly lower for patients treated with DRG stimulation compared to 
patients with SCS. The authors conclude that DRG stimulation provides precisely targeted 
stimulation which is beneficial compared to SCS as a therapy for patients with CRPS or 
causalgia of the lower extremities (32). Although these results are encouraging in favour of 
DRG stimulation, more than 10% of the included patients suffered from groin pain, which 
is nearly impossible to treat with SCS, and groin pain is certainly not CRPS. In addition, not 
all included CRPS patients were diagnosed according to the new IASP diagnostic criteria 
for CRPS. Nevertheless, DRG stimulation seems to offer more-targeted stimulation than 
SCS, which has potential clinical implications. It may be possible to use DRG stimulation to 
treat patients with foot or knee pain, which are more difficult locations to target with SCS.
CRPS ConfinEd to thE KnEE?
In the last few years, we have seen a group of patients in our Center for Pain Medicine with 
pain and other symptoms and signs normally seen in CRPS but without a distal spread 
in the extremity, confined instead to just the knee(s). A specific diagnosis was not made 
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in most of these cases, and the complaints were symptomatically treated with several 
medications and/or invasive procedures. Over time, the thought arose that perhaps these 
complaints were due to CRPS, because the clinical picture of the patients had several 
similarities with this diagnosis, and that perhaps CRPS confined to the knee would be a 
clinical entity in its own right.
Ernst Baur appears to have been the first to describe patients with possible CRPS confined 
to the knee, reporting on three such patients in 1954, at least one of whom retrospectively 
would fulfil the Budapest criteria set based on the signs and symptoms described (33). 
Over the years, many different strategies have been used to confirm and/or diagnose CRPS 
confined to the knee in addition to the standard diagnostic criteria set. In line with Evans, 
pain relief from a lumbar sympathetic block was considered a confirmation of or an ad-
ditional criterion for the diagnosis (34, 35). A retrospective study of 60 patients diagnosed 
with CRPS confined to the knee revealed that a surgical procedure (arthroscopic) was the 
most common event in developing CRPS (36). Several authors have concluded that CRPS 
is in fact an uncommon and unrecognized cause of knee pain that can follow some sort 
of trauma (37-39). This fact results in a delay in diagnosing and starting the appropriate 
treatment (40). Unfortunately, as earlier literature showed, patients with CRPS confined to 
the knee have responded poorly to any sort of treatment (34, 41, 42). Our own experience 
confirms the difficulty of treating these patients, because they have a temporary response 
or no response at all. Even with SCS we have seen mixed results. But as seen in other stud-
ies, DRG stimulation has the potential to treat difficult locations, so perhaps this therapy 
can be successful for patients with CRPS confined to the knee.
thiS thESiS
The aim of this thesis is to find the answers to our following research questions;
1. Is CRPS of the knee an existing clinical entity?
2. Is there a difference between the development of CRPS confined to the knee and that 
of CRPS of more distal locations (e.g., the ankle/foot or the wrist/hand)?
3. Is there a difference between the clinical course of CRPS confined to the knee and that 
of CRPS of more distal locations (e.g., the ankle/foot or the wrist/hand)?
4. Does DRG stimulation have a value in the treatment of CRPS confined to the knee?
In summary, we aim to confirm the location of, increase the knowledge of, facilitate the 
recognition of and provide a potential treatment for CRPS confined to the knee.
13
General introduction
REfEREnCES
 1. Sudeck P. Ueber die acute Entzundli-
che Knochenatrophie. Arch Klin Chir. 
1900(62):147-56.
 2. Iolascon G, de Sire A, Moretti A, Gimi-
gliano F. Complex regional pain syndrome 
(CRPS) type I: historical perspective and 
critical issues. Clin Cases Miner Bone Metab. 
2015;12(Suppl 1):4-10.
 3. Evans JA. Reflex sympathetic dystrophy. 
Surg Gynecol Obstet. 1946;82:36-43.
 4. Stanton-Hicks M, Janig W, Hassenbusch S, 
Haddox JD, Boas R, Wilson P. Reflex sym-
pathetic dystrophy: changing concepts and 
taxonomy. Pain. 1995;63(1):127-33.
 5. Allen G, Galer BS, Schwartz L. Epidemiol-
ogy of complex regional pain syndrome: a 
retrospective chart review of 134 patients. 
Pain. 1999;80(3):539-44.
 6. Borchers AT, Gershwin ME. The clinical rel-
evance of complex regional pain syndrome 
type I: The Emperor’s New Clothes. Autoim-
mun Rev. 2017;16(1):22-33.
 7. Veldman PH, Reynen HM, Arntz IE, Goris RJ. 
Signs and symptoms of reflex sympathetic 
dystrophy: prospective study of 829 pa-
tients. Lancet. 1993;342(8878):1012-6.
 8. Reinders MF, Geertzen JH, Dijkstra PU. Com-
plex regional pain syndrome type I: use of 
the International Association for the Study 
of Pain diagnostic criteria defined in 1994. 
Clin J Pain. 2002;18(4):207-15.
 9. Bruehl S, Harden RN, Galer BS, Saltz S, Ber-
tram M, Backonja M, et al. External valida-
tion of IASP diagnostic criteria for Complex 
Regional Pain Syndrome and proposed 
research diagnostic criteria. International 
Association for the Study of Pain. Pain. 
1999;81(1-2):147-54.
 10. Harden RN, Oaklander AL, Burton AW, Perez 
RS, Richardson K, Swan M, et al. Complex 
regional pain syndrome: practical diagnos-
tic and treatment guidelines, 4th edition. 
Pain Med. 2013;14(2):180-229.
 11. Kosek E, Cohen M, Baron R, Gebhart GF, 
Mico JA, Rice AS, et al. Do we need a third 
mechanistic descriptor for chronic pain 
states? Pain. 2016;157(7):1382-6.
 12. Birklein F, Schlereth T. Complex regional 
pain syndrome-significant progress in 
understanding. Pain. 2015;156 Suppl 1:S94-
103.
 13. Birklein F, Schmelz M. Neuropeptides, 
neurogenic inflammation and complex 
regional pain syndrome (CRPS). Neurosci 
Lett. 2008;437(3):199-202.
 14. Tan EC, Oyen WJ, Goris RJ. Leukocytes in 
Complex Regional Pain Syndrome type I. 
Inflammation. 2005;29(4-6):182-6.
 15. Birklein F, Schmelz M, Schifter S, Weber 
M. The important role of neuropeptides in 
complex regional pain syndrome. Neurol-
ogy. 2001;57(12):2179-84.
 16. Laferriere A, Millecamps M, Xanthos DN, 
Xiao WH, Siau C, de Mos M, et al. Cutaneous 
tactile allodynia associated with micro-
vascular dysfunction in muscle. Mol Pain. 
2008;4:49.
 17. Beerthuizen A, van ‘t Spijker A, Huygen FJ, 
Klein J, de Wit R. Is there an association 
between psychological factors and the 
Complex Regional Pain Syndrome type 1 
(CRPS1) in adults? A systematic review. 
Pain. 2009;145(1-2):52-9.
 18. Beerthuizen A, Stronks DL, Huygen FJ, 
Passchier J, Klein J, Spijker AV. The associa-
tion between psychological factors and the 
development of complex regional pain syn-
drome type 1 (CRPS1)--a prospective multi-
center study. Eur J Pain. 2011;15(9):971-5.
 19. Bussa M, Guttilla D, Lucia M, Mascaro A, 
Rinaldi S. Complex regional pain syndrome 
type I: a comprehensive review. Acta Anaes-
thesiol Scand. 2015;59(6):685-97.
 20. Perez RS, Zollinger PE, Dijkstra PU, Thom-
assen-Hilgersom IL, Zuurmond WW, Rosen-
brand KC, et al. Evidence based guidelines 
Chapter I
14
for complex regional pain syndrome type 1. 
BMC Neurol. 2010;10:20.
 21. Bruehl S, Harden RN, Galer BS, Saltz S, 
Backonja M, Stanton-Hicks M. Complex 
regional pain syndrome: are there distinct 
subtypes and sequential stages of the 
syndrome? Pain. 2002;95(1-2):119-24.
 22. Bharwani K, Dirckx M, Huygen F. Complex 
regional pain syndrome: diagnosis and 
treatment. Bja Educ. 2017;17(8):262-8.
 23. Melzack R, Wall PD. Pain mechanisms: a 
new theory. Science. 1965;150(3699):971-9.
 24. Shealy CN, Mortimer JT, Reswick JB. Electri-
cal inhibition of pain by stimulation of the 
dorsal columns: preliminary clinical report. 
Anesth Analg. 1967;46(4):489-91.
 25. Shealy CN, Taslitz N, Mortimer JT, Becker DP. 
Electrical inhibition of pain: experimental 
evaluation. Anesth Analg. 1967;46(3):299-
305.
 26. Kemler MA, Barendse GA, van Kleef M, de 
Vet HC, Rijks CP, Furnee CA, et al. Spinal 
cord stimulation in patients with chronic 
reflex sympathetic dystrophy. N Engl J Med. 
2000;343(9):618-24.
 27. Kemler MA, De Vet HC, Barendse GA, Van 
Den Wildenberg FA, Van Kleef M. The effect 
of spinal cord stimulation in patients with 
chronic reflex sympathetic dystrophy: two 
years’ follow-up of the randomized con-
trolled trial. Ann Neurol. 2004;55(1):13-8.
 28. Kemler MA, de Vet HC, Barendse GA, van 
den Wildenberg FA, van Kleef M. Effect 
of spinal cord stimulation for chronic 
complex regional pain syndrome Type I: 
five-year final follow-up of patients in a 
randomized controlled trial. J Neurosurg. 
2008;108(2):292-8.
 29. Liem L, Russo M, Huygen FJ, Van Buyten 
JP, Smet I, Verrills P, et al. A multicenter, 
prospective trial to assess the safety and 
performance of the spinal modulation dor-
sal root ganglion neurostimulator system in 
the treatment of chronic pain. Neuromodu-
lation. 2013;16(5):471-82; discussion 82.
 30. Van Buyten JP, Smet I, Liem L, Russo M, 
Huygen F. Stimulation of dorsal root ganglia 
for the management of complex regional 
pain syndrome: a prospective case series. 
Pain Pract. 2015;15(3):208-16.
 31. Schott GD. Mechanisms of causalgia and 
related clinical conditions. The role of the 
central and of the sympathetic nervous 
systems. Brain. 1986;109 ( Pt 4):717-38.
 32. Deer TR, Levy RM, Kramer J, Poree L, 
Amirdelfan K, Grigsby E, et al. Dorsal root 
ganglion stimulation yielded higher treat-
ment success rate for complex regional 
pain syndrome and causalgia at 3 and 12 
months: a randomized comparative trial. 
Pain. 2017;158(4):669-81.
 33. Baur E. [Post traumatic dystrophy of the 
knee] Beitrag zur posttraumatischen 
Dystrophie des Kniegelenkes. Z Unfallmed 
Berufskr. 1954;47(3):224-32.
 34. Cameron HU, Park YS, Krestow M. Reflex 
sympathetic dystrophy following total 
knee replacement. Contemp Orthop. 
1994;29(4):279-81.
 35. Malhotra R, Dhingra SS, Padhy AK, Kumar 
R, Ravishankar U. Reflex sympathetic 
dystrophy of the patello-femoral joint. 
Diagnosis and relevance. Clin Nucl Med. 
1995;20(12):1058-60.
 36. O’Brien SJ, Ngeow J, Gibney MA, Warren RF, 
Fealy S. Reflex sympathetic dystrophy of 
the knee. Causes, diagnosis, and treatment. 
Am J Sports Med. 1995;23(6):655-9.
 37. Tietjen R. Reflex sympathetic dystrophy 
of the knee. Clin Orthop Relat Res. 
1986(209):234-43.
 38. Coughlan RJ, Hazleman BL, Thomas 
DP, Sattelle L, Crisp AJ, Jenner JR, et al. 
Algodystrophy: a common unrecognized 
cause of chronic knee pain. Br J Rheumatol. 
1987;26(4):270-4.
 39. Katz MM, Hungerford DS, Krackow KA, 
Lennox DW. Reflex sympathetic dystrophy 
as a cause of poor results after total knee 
arthroplasty. J Arthroplasty. 1986;1(2):117-
24.
15
General introduction
 40. Reuben SS, Sklar J. Intravenous regional 
anesthesia with clonidine in the manage-
ment of complex regional pain syndrome 
of the knee. J Clin Anesth. 2002;14(2):87-91.
 41. Ogilvie-Harris DJ, Roscoe M. Reflex sympa-
thetic dystrophy of the knee. J Bone Joint 
Surg Br. 1987;69(5):804-6.
 42. Miller RL. Reflex sympathetic dystrophy. 
Orthop Nurs. 2003;22(2):91-9; quiz 100-1.

Chapter II
Complex regional pain 
syndrome type I of the knee: A 
systematic literature review
Bussel, CM van
Stronks DL,
Huygen FJPM
European Journal of  Pain. 2014 Jul;18(6):766-73
Chapter II
18
aBStRaCt
Background and Objective: In our Center for Pain Medicine, a group of patients reported 
to have symptoms possibly attributable to complex regional pain syndrome (CRPS) of 
only the knee(s). Therefore, this study aimed to investigate whether the literature reports 
on patients with CRPS type I in the knee(s) alone and, if so, to summarize the reported 
diagnostics, aetiology and treatment strategies of CRPS of the knee(s).
Databases and Data treatment: Medline, Embase, Cochrane Library, PubMed and Web of 
Science were searched for articles focusing on a painful disorder of the knee, most likely 
CRPS type I. Screening on title and abstract was followed by full-text reading and search-
ing of reference lists to determine the final set of relevant articles.
Results: Of the 513 articles identified, 31 met the inclusion criteria. These articles reported 
on a total of 368 patients diagnosed with CRPS of the knee(s) based on the diagnostic 
criteria used at the time of publication. Knee surgery, especially arthroscopic surgery, was 
the most common inciting event in developing CRPS of the knee(s). Various treatment 
strategies were applied with variable outcomes.
Conclusions: The scientific literature does report cases of CRPS type I of only the knee(s). 
This applies when using the diagnostic criteria prevailing at the time of publication and, 
obviously for a smaller number of cases, also when using the current Budapest criteria 
set. Arthroscopic knee surgery is described multiple times as the inciting event. We recom-
mend to include CRPS of the knee in future research on the aetiological mechanisms of 
and optimal treatment for CRPS.
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1. intRoduCtion
Complex regional pain syndrome (CRPS) type I, formerly known as reflex sympathetic 
dystrophy (RSD) or algodystrophy, is a collection of locally appearing painful conditions 
following a trauma, which mainly occur distally in the affected limb and exceed in both 
intensity and duration the expected clinical course of the original trauma. The symptoms 
are not confined to the innervation zone of an individual nerve (1). Involvement of the 
whole extremity can occur. The main clinical features of CRPS are continuing pain, and 
sensory, vasomotor, sudomotor and motor trophic disturbances (2). CRPS is a clinical 
diagnosis based on signs and symptoms described in criteria sets and, over the years, 
different diagnostic criteria sets have been developed. Currently, the use of the Budapest 
criteria set is recommended (3). Laboratory tests and radiology have only limited addi-
tional value in the diagnostic process and are mainly used to exclude another diagnosis. 
The natural history of CRPS is not always positive and can result in permanent disability. 
Treatment remains a challenge because the underlying pathophysiologic mechanisms are 
only partly understood (4).
In our expert center for CRPS, we receive referrals from throughout the Netherlands and 
see many patients for a second opinion. Our interest was drawn by a group of patients 
with CRPS-like symptoms confined only to the knee(s); this was the rationale to perform 
this systematic review.
The following research questions were addressed: ‘Are there any descriptions in the 
medical literature of complex regional pain syndrome type I only affecting the knee(s), 
and diagnosed with the criteria used at the moment of publication?’ and ‘If so, what does 
the literature report on diagnostics, etiology and treatment of complex regional pain 
syndrome type I affecting only the knee(s)?’
2. litERatuRE SEaRCh MEthodS
2.1 Search strategy
To find relevant articles, searches were made in Embase, OVID-SP, Cochrane Central, 
PubMed and Web of Science covering the period 21 December 2012 to 4 January 2013.
The search strategy was divided into elements for CRPS and those for the knee. For 
optimal results from all five databases, elements from both groups were applied in the 
correct format for the search in each database. Details on the strategies and results are 
given in Appendix 1.
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2.2 inclusion/exclusion criteria
Articles were not excluded on the basis of study design. After the search, the title and ab-
stract of each article were checked for relevance. Because the search was made in differ-
ent databases, Endnote X5 for Windows (Thomson Reuters, New York, NY, USA) was used 
to ensure that no article was included more than once. The main topic of the article had 
to be a painful disorder of the knee, most likely diagnosed as CRPS type I. The reference 
lists of the identified articles were checked for additional studies possibly missed by the 
search strategies.
Excluded articles had either the wrong main topic, e.g., patients suffered from CRPS 
type I in a location other than the knee, or patients were suffering from a partial CRPS 
type I. Partial CRPS type I was considered by authors of some articles as being a CRPS-like 
syndrome, not completely matching the criteria used at the time of publication. Other 
excluded articles described patients with CRPS of the knee attributable to verifiable nerve 
damage (this disorder was most likely CRPS type II). Also excluded were articles written in 
languages other than Dutch, English or German, because none of the authors mastered 
these languages, as well as studies involving children with CRPS aged ≤ 18 years.
3. RESultS
After filtering with EndNote, the search resulted in 513 articles. After screening the titles 
and abstracts, 436 articles were excluded either because the main topic was incorrect, or 
children aged ≤ 18 years were involved, or the articles described CRPS as a result of nerve 
damage. This left 77 articles of which 26 were written in French, Italian, Spanish or Por-
tuguese and were therefore excluded. This left 51 articles. After full-text reading of these 
papers, another 20 were excluded because CRPS was only considered as a differential 
diagnosis. This left 31 relevant articles to present in this review: 10 case reports, 10 case 
series, five retrospective studies, five prospective studies and one case-controlled study. 
Checking the reference lists of these articles yielded no additional relevant publications. A 
flow chart showing the in- and exclusion of the articles is presented in Appendix 2.
3.1 diagnostics
3.1.1 Criteria sets
The 31 included articles comprised a total of 368 patients diagnosed with RSD, algodys-
trophy or CRPS based on criteria sets used at the time of publication. Table 1 shows how 
many patients (based on the symptoms mentioned in the articles) met the various criteria 
sets used over time in diagnosing CRPS, i.e., the criteria of Veldman, the International 
Association for the Study of Pain (IASP) criteria, the Bruehl and Harden criteria, and the 
Budapest criteria. In 187 patients, based on the symptoms mentioned in the articles, it 
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was not possible to confirm whether the patients met one or more of the criteria sets. 
Nevertheless, these patients were diagnosed by the authors as having RSD, algodystrophy 
or CRPS of the knee(s) (5-17).
3.1.2 Lumbar sympathetic blockade
Six articles were found in which the authors described using the relief of symptoms after 
a lumbar sympathetic blockade as a confirmation, or as an (additional) criterion, for diag-
nosing RSD or CRPS in patients with extensive knee pain.
The authors of five publications stated that CRPS can be confirmed by at least partial 
relief of the symptoms after receiving a lumbar sympathetic blockade, besides clinical ap-
pearance suggestive for RSD or CRPS. Of these, Cooper et al. and Braverman et al. reported 
on patients who matched the Bruehl and Harden, IASP, and the Budapest criteria set (4, 
18). Because the authors of the other three publications did not describe (all) the symp-
toms patients were suffering from, we were unable to confirm their diagnosis of CRPS or 
RSD based on the criteria sets (8, 15, 16).
In contrast, Neuschwander et al. used (partial) relief of symptoms after a lumbar sympa-
thetic blockade only as confirmation of the diagnosis CRPS or RSD (17).
3.1.3 Radiographs/Bone scans
In 13 articles, the authors used a form of radiology as a diagnostic tool or as a confirmation 
of the diagnosis of RSD, algodystrophy or CRPS of the knee.
Finsterbush et al. used abnormalities on a skyline view of the patellofemoral joint or a 
bone scan as an additional criterion (besides the clinical appearance of the patients) in 
diagnosing RSD of the knee (19). Malhotra et al. used a three-phase bone scan to substanti-
ate the diagnosis of RSD, when RSD was suspected on the basis of clinical appearance (15).
Radiographic investigation of the knee showed patchy bone atrophy in five studies 
involving patients already diagnosed with RSD of the knee (5, 7, 9-11).
table 1. Multiple-response frequency table of the included patients meeting the criteria sets
Criteria set used:
Meeting the criteria set
Percentage of casesn %
Veldman 4 0.85 1.09
Bruehl and Harden 56 11.87 15.22
Budapest 79 16.67 21.47
IASP 148 31.52 40.22
Not possible to confirm 187 39.09 50.81
Total 474 100.00 128.81
Note: Because some patients met more than one criteria set, the percentage of cases does not sum to 100
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O’Brien et al. reported that 19 of the 60 patients diagnosed with RSD had positive find-
ings on pre-treatment bone scans; they stated that if a patient had asymmetry of uptake 
in the knee(s) on the bone scan this is a supportive but not necessary finding in diagnosing 
RSD (16). Loew and Isakov et al. stated that pathological findings on a three-phase bone 
scan can be supportive in the clinical diagnosis of RSD of the knees. The scans revealed 
increased bone uptake in the patellae, femoral condyles or upper part of the tibia (2, 20).
In all patients who developed RSD or CRPS after renal transplantation, radiographs 
showed patchy osteopenia and bone scintigraphy showed increased uptake in the af-
fected areas; the authors considered these findings as supportive in diagnosing RSD or 
CRPS (21-23).
3.2 aetiology
3.2.1 CRPS after (arthroscopic) knee surgery
The authors of ten articles reported on patients with RSD or CRPS of the knee after under-
going (arthroscopic) surgery of the knee (6, 11-14, 16, 20, 24-26).
Cooper et al. reported on a group of 14 patients of whom 11 underwent a patellar opera-
tion before the onset of RSD symptoms (18). The authors of three articles reported on 32 
patients who developed RSD of the knee after undergoing a total knee replacement (4, 13, 
19).
Burns et al. compared eight patients with CRPS of the knee after total knee arthroplasty 
with patients who had no complaints after total knee arthroplasty and with patients with 
preoperative osteoarthritic knees; they stated that prompt diagnosis and early treatment 
is most important in treating CRPS of the knee (27). Others stated that CRPS should also be 
considered when a knee does not recover after knee surgery (8).
3.2.2 CRPS after trauma or injury
In 1954 three cases of RSD of the knee after a distortion or contusion were described 
by Baur (5). In 1995, Isakov et al. presented a case of RSD of the knees that developed 
after burning both knees (2). Miller reported a case of RSD after injuring the left knee; the 
patient felt a “twinge” and within two weeks developed intense pain and other symptoms 
(28). In another case, a left patella fracture and emergency surgery was complicated by 
developing CRPS (29).
A study of 67 patients with unexplained knee pain revealed (in retrospect) that 14 
patients were suffering from RSD; all of these patients had injured one knee and had 
persistent complaints (9).
Ten studies described patients with RSD or CRPS of the knee after a minor twist, injury 
or trauma (10-12, 15-19, 26, 30, 31).
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3.2.3 Non-traumatic CRPS
Two patients were described as being diagnosed with RSD or algodystrophy of the knee 
without a known trauma or injury before the symptoms occurred (7, 16).
The authors of three articles reported the occurrence of RSD in the lower extremities 
in patients after renal transplantation. A total of seven patients had severe pain in one or 
both of the knees and ankles; clinical examination revealed increased local temperature, 
trophic changes and periarticular soft tissue swelling (21-23).
3.3 treatment
In the included articles many different strategies are described in the treatment of CRPS of 
the knee, with variable results.
In 11 articles, the authors mentioned the use of physiotherapy (besides other therapy) 
in patients with CRPS or RSD of the knee (2, 4, 7, 12, 14, 15, 19, 20, 24, 27, 29).
A lumbar sympathetic blockade was performed in 12 studies; this blockade was 
sometimes used as a single therapy and sometimes combined with another therapy, 
e.g., physiotherapy (4, 8, 11-14, 16-20, 25). Seven patients with the diagnosis CRPS of the 
knee were treated with intravenous regional anaesthesia with clonidine and the authors 
reported this to be a useful treatment in the management of CRPS of the knee, without 
significant side-effects (26). A study of 30 patients, all diagnosed with CRPS according to 
the IASP criteria, examined the efficacy of shockwave therapy in the management of CRPS 
of the medial femoral condyle; only one patient had persisting pathology signs on MRI at 
six months follow-up (32).
Ching et al. reported on a patient with Behçet’s disease and CRPS of her left knee (diag-
nosed according to the Budapest criteria set). The patient was given thalidomide for the 
Behçet’s disease, which resulted in an unexpected gradual improvement of the pain in her 
knee (30). Ogilvie-Harris and Roscoe described 19 patients suffering from extensive knee 
pain and (retrospectively) 11 of these patients met the IASP criteria in diagnosing CRPS; 
the remaining eight patients did not meet any of the criteria sets. All patients received 
non-steroidal anti-inflammatory drugs (NSAIDs) and intensive physiotherapy and, if a 
patient did not respond, he/she received a sympathetic blockade (12).
Burns et al. compared eight patients with CRPS of the knee (according to the Bruehl 
and Harden, IASP and Budapest criteria), which developed after a total knee arthroplasty, 
table 2. Number and percentage of reported eliciting factors
aetiology Number of cases (n) Percentage (%)
Trauma or injury 197 53.53
(Artroscopic) knee surgery 162 44.02
Non traumatic 9 2.45
Total 368 100
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with eight patients with uncomplicated total knee arthroplasty. All patients received 
NSAIDs and physiotherapy and, if needed, manipulation under anaesthesia. The authors 
concluded that, when managed early, patients complicated with CRPS after total knee 
arthroplasty have a similar prognosis to patients with uncomplicated total knee arthro-
plasty (27).
Mak et al. reported on a man with CRPS of the knee (diagnosed according to the Bruehl 
and Harden criteria set) that developed after a patella fracture; the patient received an 
infusion of bupivacaine with fentanyl for five days, continuous passive stretching at night-
time and daily physiotherapy, resulting in a pain score of zero and sustained improvement 
in mobilization and function (29). Another patient with the diagnosis algodystrophy of the 
knee received NSAIDs, prednisone and physiotherapy, and was considered to be cured af-
ter two years of therapy (7). Furthermore, the patient described by Malhotra et al. with RSD 
of the knee had almost complete relief of the symptoms after physiotherapy, microwave 
diathermy and NSAIDs (15).
Two case reports reported on patients with CRPS or RSD of the knee who, despite vari-
ous pain medication, physiotherapy, transcutaneous electrical nerve stimulation (TENS) 
and passive motion, never became symptom-free of CRPS of the knee (24, 28).
The authors of seven studies state that therapy should be started as soon as possible to 
ensure the best outcome for patients (4, 11, 12, 14, 18, 19, 27). This is in contrast to a study 
performed by O’Brien et al. These authors included 60 patients diagnosed with RSD of the 
knee who were divided into three groups; early (< 6 months), medium (6-12 months) and 
late (>12 months) diagnosis. The study showed no difference between the three groups 
of RSD patients in outcome (knee pain, other knee symptoms and range of motion) after 
treatment (16).
4. diSCuSSion and ConCluSionS
This review investigated whether the literature describes patients suffering from CRPS 
type I of only the knee(s) and, if so, what the aetiology, diagnostics and treatment were 
in those patients.
4.1 limitations in the inclusion of articles
Our search included descriptions of CRPS, RSD, algodystrophy, and derivatives of these 
terms and descriptions of the knee. CRPS, RSD and algodystrophy are only three of the 
many descriptions used over the course of time for (or related to) CRPS. Therefore, we may 
have missed some publications if the authors used yet another description for the same 
disorder. In addition, we were unable to examine the studies published in the French, 
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Italian, Spanish or Portuguese language. Of these 26, only nine studies were potentially 
valuable. We consider this as a possible shortcoming of this review.
4.2 diagnosis
All the articles included in this review were studies in which patients are described as 
having RSD, algodystrophy or CRPS of the knee(s). For the diagnosis of these disorders, 
some authors used only the clinical appearance, others claimed that abnormalities on 
radiological investigations are needed (beside clinical appearance), and yet others state 
that at least partial relief of the symptoms after a lumbar sympathetic blockade is needed 
to make a diagnosis of CRPS. In addition, some authors did not describe all the symptoms 
(besides extensive knee pain) a patient was suffering from after minor trauma or surgery; 
in these cases, we were unable to confirm their diagnosis.
Radiographs and bone scans were used in almost every study included in this review. 
In seven studies, abnormalities found on radiographs (besides the clinical features) were 
considered supportive in diagnosing RSD or CRPS. The authors of one article stated that 
the use of a skyline view of the patella would be helpful because, so they say, in RSD of 
the knee the patella is always involved (19). Currently, however, the diagnosis of CRPS is 
clinically based and no further tests are acquired.
Some authors stated that RSD is a condition ‘better overtreated than underdiagnosed’ 
(14). Tietjen concluded that if the existence of CRPS of the knee was more widely known 
in the medical world, this would help in diagnosing patients with extensive knee pain after 
a trauma, injury or surgery as patients with CRPS. For knee pain, he advises the use of 
arthroscopic techniques to rule out causes other than RSD, thereby reducing the amount 
of unnecessary surgery on knees with RSD (9). His study was published in 1986, and after 
that date several cases of RSD or CRPS have been described (as shown in this review) after 
arthroscopic knee surgery. Therefore, the question arises whether we should consider 
arthroscopic knee surgery to be a risk factor for developing CRPS of the knee.
4.3 treatment
The literature is inconsistent and/or unclear about the best time to start therapy and which 
therapy should be applied to treat CRPS. Comparison of the studies in this review was dif-
ficult because of the differences in study design, and the variable time after diagnosis and 
start of treatment. Moreover, the authors used different treatment strategies and primary 
outcome measures. Uncertainty about the best treatment for CRPS of the knee seems to 
be no different than uncertainty for CRPS on other (more distal) locations.
4.4 Budapest criteria set
The Budapest criteria set is currently recommended for the diagnosis of CRPS. One of the 
requirements in diagnosing CRPS according to this set is continuing pain, which is dispro-
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portionate to the inciting event. The criteria set does not include that the patient must 
have at least partial relief of the symptoms after a lumbar sympathetic blockade, or that 
radiographs or bone scans must show abnormalities in the affected area when compared 
with the unaffected area. This could imply that patients with a diagnosis of RSD/CRPS 
without any inciting event, or based on their clinical appearance and at least partial relief 
of the symptoms after a blockade, or based on their clinical appearance and radiographic 
evidence of abnormalities, would nowadays probably not receive the diagnosis of CRPS.
In conclusion, our review of the literature reporting on CRPS affecting only the knee(s) 
reveals that at least 79 patients (more than 20% of the reported cases) are described who 
met the current Budapest diagnostic criteria set. Therefore, we conclude that patients 
suffering from CRPS of only the knee(s), have been described in the medical literature.
In addition, we summarized the authors’ description of the diagnostics, aetiology and 
treatment of CRPS affecting only the knee(s). On this basis, we recommend to consider 
CRPS of only the knee(s) as a medical entity, similar to the more frequently described CRPS 
of the hand or foot. Because CRPS as a medical condition is only partially understood, we 
recommend that future research on the aetiological mechanisms and optimal treatment 
of CRPS should also include CRPS of only the knee. That CRPS of the knee often appeared 
after arthroscopic knee surgery is an important finding; this implies that this procedure is 
a possible inciting factor for the development of CRPS; the same applies when a knee does 
not recover adequately after an arthroscopic knee surgery.
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aPPEndiX 1
Search strategies in detail
Embase: 441 hits
(‘complex regional pain syndrome’/exp OR (CRPS OR ‘complex regional pain’ OR Sudeck* OR 
Sudek* OR Suedeck* OR (RSD* AND (reflex* OR sympathet* OR dystroph*)) OR algodystroph* OR 
algesidystroph* OR algoneurodystroph* OR ((posttraumatic OR ‘post traumatic’ OR sympathet* 
OR reflex*) NEAR/3 (osteoporos* OR dystroph*))):ab,ti) AND (Knee/de OR ‘knee meniscus’/de 
OR ‘patellofemoral joint’/de OR ‘knee ligament’/exp OR ‘knee injury’/exp OR ‘knee disease’/exp 
OR ‘knee surgery’/exp OR ‘knee arthroscopy’/de OR ‘below knee amputation’/de OR (knee* OR 
menisc* OR genu* OR genopath* OR patell* OR femoropatellar* OR (semilun* NEAR/3 (bone* 
OR cartilage*))):ab,ti)
OVID-SP: 252 hits
(exp “complex regional pain syndromes”/ OR (CRPS OR “complex regional pain” OR Sudeck* 
OR Sudek* OR Suedeck* OR (RSD* AND (reflex* OR sympathet* OR dystroph*)) OR algodys-
troph* OR algesidystroph* OR algoneurodystroph* OR ((posttraumatic OR “post traumatic” 
OR sympathet* OR reflex*) ADJ3 (osteoporos* OR dystroph*))).ab,ti.) AND (Knee/ OR exp “knee 
joint”/ OR “knee meniscus”/ OR exp “Medial Collateral Ligament, Knee”/ OR “Genu Valgum”/ 
OR exp “Knee Injuries”/ OR “Osteoarthritis, Knee”/ OR “Patellofemoral Pain Syndrome”/ OR 
(knee* OR menisc* OR genu* OR genopath* OR patell* OR femoropatellar* OR (semilun* ADJ3 
(bone* OR cartilage*))).ab,ti.)
Cochrane Central: 4 hits
((CRPS OR “complex regional pain” OR Sudeck* OR Sudek* OR Suedeck* OR (RSD* AND 
(reflex* OR sympathet* OR dystroph*)) OR algodystroph* OR algesidystroph* OR algoneurodys-
troph* OR ((posttraumatic OR “post traumatic” OR sympathet* OR reflex*) NEAR/3 (osteoporos* 
OR dystroph*))) AND (knee* OR menisc* OR genu* OR genopath* OR patell* OR femoropatellar* 
OR (semilun* NEAR/3 (bone* OR cartilage*)))):ab,ti
PubMed as supplied by publisher: 3 hits
(CRPS[tiab] OR complex regional pain*[tiab] OR Sudeck*[tiab] OR Sudek*[tiab] OR 
Suedeck*[tiab] OR (RSD*[tiab] AND (reflex*[tiab] OR sympathet*[tiab] OR dystroph*[tiab])) 
OR algodystroph*[tiab] OR algesidystroph*[tiab] OR algoneurodystroph*[tiab] OR 
((posttraumatic[tiab] OR post traumatic*[tiab] OR sympathet*[tiab] OR reflex*[tiab]) AND 
(osteoporos*[tiab] OR dystroph*[tiab]))) AND (knee*[tiab] OR menisc*[tiab] OR genu*[tiab] OR 
genopath*[tiab] OR patell*[tiab] OR femoropatellar*[tiab] OR (semilun*[tiab] AND (bone*[tiab] 
OR cartilage*[tiab]))) AND publisher[sb]
Web of Science: 158 hits
TS=((CRPS OR “complex regional pain” OR Sudeck* OR Sudek* OR Suedeck* OR (RSD* AND 
(reflex* OR sympathet* OR dystroph*)) OR algodystroph* OR algesidystroph* OR algoneurodys-
troph* OR ((posttraumatic OR “post traumatic” OR sympathet* OR reflex*) NEAR/3 (osteoporos* 
OR dystroph*))) AND (knee* OR menisc* OR genu* OR genopath* OR patell* OR femoropatellar* 
OR (semilun* NEAR/3 (bone* OR cartilage*))))
Total amount of articles: 858. After removing duplicates: 513
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aPPEndiX 2
flow Chart
Titles and abstracts identified and 
screened
 
n = 513
Publications meeting inclusion 
criteria
 
n = 51
Excluded n = 436
Wrong main topic   n = 373
Other area affected   n = 35
CRPS type II of the knee   n = 7
Children with CRPS   n = 21
Foreign language   n = 26
 
Publications included n = 31
Prospective/Retrospective studies   n = 10
Case series   n = 10
Case reports   n = 10
Case-controlled study   n = 1
After full tekst reading excluded
n = 20
CRPS as differential diagnosis   n = 20
Studies identified from checking 
the reference lists   n = 0
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aBStRaCt
Objective: To compare the phenotypes of patients with complex regional pain syndrome 
(CRPS) of the knee to those with CRPS of the ankle/foot.
Setting: A retrospective study.
Subjects: Patients with CRPS of the knee and patients with CRPS of the ankle/foot.
Methods: We used electronic patient databases to identify patients with CRPS of the 
knee and patients with CRPS of the ankle/foot. The following variables were recorded: 
age, gender, duration of complaints, initial injury, and symptoms and signs. Frequency 
distributions and statistical significant differences between the groups were determined.
Results: Included were 50 patients with CRPS of the knee and 64 patients with CRPS of the 
ankle/foot. These patients were all diagnosed with CRPS according to the criteria used at 
the time of diagnosis. No significant differences were found in demographic characteris-
tics. A few symptoms and signs appeared to be proportionally more prevalent in patients 
with CRPS of the ankle/foot. However, patients with CRPS of the knee suffered significantly 
longer from the disease than patients with CRPS of the ankle/foot.
Conclusions: Some signs and symptoms appeared to be statistically significant more 
prevalent in CRPS of the ankle/foot than in CRPS confined to the knee. We conclude that 
the phenotypes of CRPS confined to the knee and CRPS of the ankle/foot are comparable, 
but not identical. This can be a reason why CRPS in patients with pain of the knee, that is 
disproportionate to the initial trauma, is sometimes not recognized.
KEywoRdS
Signs, symptoms, phenotype, complex regional pain syndrome, knee, ankle/foot
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Phenotypes of knee and ankle/foot CRPS
intRoduCtion
Complex regional pain syndrome (CRPS) is a painful, potentially disabling disease. The 
clinical features include pain, sensory, sudomotor/vasomotor disturbances, impaired 
motor function and trophic changes (1). Diagnosing CRPS is based on the patient history 
(symptoms) and the physical examination (signs). Symptoms are defined as subjective; 
that is, what the patient tells the physician during the visit to the outpatient clinic. Signs 
are defined as objective; that is, what the physician finds during the physical examination. 
CRPS can appear after a fracture, after surgery, and even spontaneous origination has 
been described (2, 3). Several diagnostic criteria sets have been used to diagnose CRPS 
(4-8). In 2012, the Taxonomy Committee of the International Association for the Study of 
Pain (IASP) validated the clinical Budapest or “new IASP” criteria for diagnosing CRPS (9).
CRPS is seldom considered as a reason of disproportionate pain of the knee. Only 
sporadic reports involving patients diagnosed with CRPS confined to the knee have been 
published (10). Nevertheless, our interest focused on a group of patients whose continuing 
pain of the knee was disproportionate to the initial trauma. Our recent systematic review 
on CRPS concluded that CRPS confined to the knee is an acknowledged entity and that 
some of these patients meet the IASP clinical Budapest diagnostic criteria for diagnosing 
CRPS (11).
Cooper et al. have described in their report that patients diagnosed with CRPS of the 
knee had continuing pain, stiffness and atrophy. In contrast, changes in skin, burning 
sensations and/or decrease range of motion were variably present (12). Our group of 
patients had, next to the continuing pain, symptoms and signs (for example changes in 
skin, decreased range of motion or asymmetry in temperature) which could be part of 
CRPS. The aim of this study was to compare the phenotype of CRPS of the ankle/foot with 
that of CRPS confined to the knee. In addition, we want to improve the knowledge of CRPS 
confined to the knee and to aid in the recognition of this diagnosis, so patients will be 
recognized as early as possible.
MEthodS
design
A retrospective study to compare the phenotype (in terms of symptoms and signs) of pa-
tients diagnosed with CRPS of the knee with that of patients with CRPS of the ankle/foot.
Patient selection
Every patient who was included in this study was referred to the outpatient clinic of our 
hospital during the period 2000-2013 with symptoms and signs possibly due to CRPS. 
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Every patient was seen by the same pain specialist (FH) or under direct supervision of this 
specialist. The diagnosis CRPS was set according to the Bruehl and Harden criteria and the 
IASP clinical Budapest criteria. For the purpose of future research, the data of the patients 
diagnosed with CRPS were entered into the database from the Trauma Related Neuronal 
Dysfunction (TREND) consortium. TREND is a Dutch knowledge consortium that integrates 
research on epidemiology, assessment technology, pharmacotherapy, biomarkers and 
genetics on CRPS and serves as a research platform in which the various research lines 
of CRPS are integrated (www.trendconsortium.nl). The data of the included patients were 
retrieved from this database. However, because the diagnosis CRPS confined to the knee 
was not (yet) well recognized, we also made a manual check of all hospital records of 
patients with the diagnostic code for CRPS, visiting the outpatient clinic of our hospital 
during the above mentioned period. Most of the patients with CRPS confined to the knee 
were identified by this procedure.
Measures
Clinical measures included demographic information (age and gender), duration of com-
plaints, precipitating injury, symptoms as reported by the patient and signs as objectified 
by the physician. Also, we recorded whether or not the patient met the currently recom-
mended IASP clinical Budapest diagnostic criteria set for diagnosing CRPS (see figure 1).
IASP Clinical Budapest Criteria in diagnosing CRPS
1. Continuing pain that is disproportionate to any inciting event
2. at least one symptom reported in at least three of the following categories:
Sensory Hyperesthesia or allodynia
Vasomotor Temperature asymmetry, skin color changes, skin color asymmetry
Sudomotor Edema, sweating changes, sweating asymmetry
Motor/trophic Decreased range of motion, motor dysfunction (weakness, tremor, dystonia), trophic changes 
(hair, nail, skin)
3. at least one sign at time of evaluation in at least two of the following categories:
Sensory Evidence of hyperalgesia (to pinprick), allodynia (to light touch, temperature sensation, deep 
somatic pressure or joint movement)
Vasomotor Evidence of temperature asymmetry (>1 C°), skin color changes or asymmetry
Sudomotor Evidence of edema, sweating changes or sweating asymmetry
Motor/trophic Evidence of decreased range of motion, motor dysfunction (weakness, tremor, dystonia), 
trophic changes (hair, nail, skin)
4. no other diagnosis can better explain the symptoms and signs
figure 1. IASP clinical Budapest criteria in diagnosing CRPS.
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Statistical analysis
Descriptive statistics were used to determine the frequencies of the demographic and 
outcome parameters. The Kolmogorov-Smirnov test was used to analyse whether or not 
parameters were normally distributed. For parameters with a normal distribution, central 
tendency and dispersion are described in terms of the mean and the standard deviation 
(SD); parameters with a non-normal distribution are described in terms of the median 
and the interquartile range (IQR). Differences between the cohorts in the proportions 
of patients exhibiting a particular sign or symptom were tested using the Fisher’s exact 
test. Differences in continuous variables were evaluated using the independent samples 
Mann-Whitney U-test or the independent samples T-test dependent on the shape of their 
distribution. For all statistics, P was set at the 0.05 level. The data were analysed using IBM 
SPSS Statistics version 21.0 (Armonk, NY: IBM Corp).
RESultS
Patients with CRPS of the ankle/foot
The data of 161 patients diagnosed at our outpatient clinic with CRPS were found in the 
TREND database. From these, 94 patients were diagnosed with CRPS of the wrist/hand and 
were therefore excluded. Of the remaining 67 patients, three patients were diagnosed with 
CRPS confined to the knee and included in the relevant group. All remaining 64 patients 
were diagnosed with CRPS of the ankle / foot.
Patients with CRPS confined to the knee
The subsequent manual search of all the hospital records resulted in the identification of 
a total of 1193 patients coded with CRPS. The patients’ charts were manually checked and 
screened on problems with one or both knees. Sixty-eight (5.7%) of them had complaints 
of the knee(s). After reading the complete charts of these 68 patients, 18 patients were ex-
cluded because they were not diagnosed by the specialist with CRPS confined to the knee. 
This resulted in a cohort of 50 patients with CRPS of the knee based on the diagnostic 
criteria set used at the time of referral to our hospital (see figure 2).
Analyses of the included patients revealed no significant difference between both 
cohorts in gender (P=0.44) or age (P=0.13), whereas there was a significant difference in 
the duration of symptoms and signs before diagnosing CRPS (P=0.02). Patients with CRPS 
of the knee suffered longer from their complaints than those with CRPS of the ankle/foot 
before diagnosis (Table 1). The duration of complaints in the knee cohort had a median of 
21.50 months (IQR 10.50-48.00) and the duration of complaints in the ankle/foot cohort 
had a median of 9.50 months (IQR 3.25-40.50). In addition, both cohorts were checked to 
see whether patients fulfilled the currently recommended IASP clinical Budapest criteria 
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for diagnosing CRPS. There was no significant diff erence in the proportion of patients in 
both groups who met the IASP clinical Budapest criteria (p=0.52): in the knee cohort, 36/50 
patients (72%) met these diagnostic criteria and in the ankle/foot cohort 47/64 patients 
(73%) fulfilled these criteria.
At presentation, all participants mentioned severe, continuing pain, with a pain score 
of at least 5 on the numeric rating scale (NRS), where 0 = no pain and 10 = worst imagin-
able pain. Table 2 summarizes the patients’ symptoms and signs. In both patient groups 
allodynia, color asymmetry, temperature asymmetry, edema and decreased range of 
motion were the most frequently reported symptoms as well as seen signs. Concerning 
the reported symptoms, a statistically significant diff erence between the groups in the 
prevalence of hyperesthesia, hyperalgesia, decreased range of motion and dystonia was 
found. With regard to the signs, a significant diff erence was found between the groups 
in hypoesthesia, hyperalgesia, color asymmetry, and sweating asymmetry. These specific 
symptoms and signs were more oft en mentioned and seen in the CRPS of the ankle/foot 
cohort.
Selection of the study 
population 
TREND 
Database
Patients with CRPS
n = 161
CRPS of the lower 
extremity
n = 67
Excluded n = 94
Patients with CRPS 
of upper extremity
Patients with CRPS 
of the ankle/foot
n = 64
Patients with CRPS 
of the knee
n = 3
Electronic Patient
Database 
Patients coded with 
CRPS
n = 1193
Patients with a 
problem of the knee
n = 68
Excluded n = 1125
 No knee problems
Patients with CRPS 
of the knee
n = 50
Excluded n = 18
 No CRPS diagnosis
Excluded n = 3
 Duplicates
figure 2. Flow chart of selection of the study population
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The precipitating events for development of CRPS are presented in table 3. In the knee 
cohort, surgery and arthroscopy were the most frequently occurring precipitating events: 
15 patients (30%) had (arthroscopic) surgery and 14 (28%) had an arthroscopy before the 
onset of CRPS. In the ankle/foot cohort, a fracture of the lower leg (20 patients, 31.3%) 
and a trauma, for example, distortion and/or inversion, (16 patients, 25%), were the most 
frequently reported precipitating events.
table 1. Characteristics of the patients by location of CRPS
Knee cohort n = 50 Ankle/Foot cohort n = 64 P
Female gender n (%) 44 (88%) 52 (81.3%) 0.44
Age/years mean (SD) 41.44 (14.37) 41.05 (16.56) 0.13
Duration/months median (IQR) 21.50 (10.50-48.00) 9.50 (3.25-40.50) 0.02*
Met the Budapest diagnostic criteria set n (%) 36 (72%) 47 (73%) 0.52
CRPS, complex regional pain syndrome; SD, standard deviation; IQR, interquartile range,
* significant difference
table 2. Symptoms (subjective) and signs (objective) by location of CRPS in 114 patients
Symptoms Signs
Knee cohort Ankle/Foot 
cohort
P
Knee cohort Ankle/Foot 
cohort
Pn (%) n (%) n (%) n (%)
Sensory
Allodynia 32 (64) 45 (70) 0.55 30 (60) 45 (70) 0.32
Hyperalgesia 17 (34) 36 (56) 0.02* 6 (12) 32 (50) <0.001*
Hyperesthesia 7 (14) 44 (69) <0.001* 11 (22) 24 (38) 0.10
Hypoesthesia 1 (2) 6 (9) 0.13 3 (6) 16 (25) 0.01*
Vasomotor
Asymmetry in temperature 40 (80) 54 (84) 0.62 34 (68) 41 (64) 0.70
Asymmetry in color 36 (72) 53 (83) 0.18 23 (46) 44 (69) 0.02*
Sudomotor
Edema 43 (86) 48 (75) 0.16 30 (60) 42 (66) 0.56
Asymmetry in sweating 14 (28) 24 (38) 0.32 0 (0) 12 (19) 0.001*
Motortrophic
Decreased range of motion 25 (50) 48 (75) 0.01* 29 (58) 46 (72) 0.16
Weakness 21 (42) 36 (56) 0.19 14 (28) 28 (44) 0.12
Trophic disturbances 20 (40) 36 (56) 0.09 19 (38) 29 (45) 0.45
Dystonia 2 (4) 20 (31) <0.001* 1 (2) 2 (3) 1.00
Tremor 5 (10) 5 (8) 0.75 2 (4) 2 (3) 1.00
CRPS, complex regional pain syndrome, * significant difference
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diSCuSSion
The aim of this retrospective study was to compare the phenotype (in terms of symptoms 
and signs) of CRPS confined to the knee to that of CRPS of the ankle/foot. The results 
indicate that a limited phenotypical variation exists, but the phenotypes are not identical.
This study included 50 patients with CRPS of the knee and 64 with CRPS of the ankle/foot. 
For reasons of comparability, we excluded patients diagnosed with CRPS of an upper ex-
tremity (i.e. the hand or wrist). All patients were diagnosed with CRPS based on the criteria 
applied at the time they visited our outpatient department. When applying the IASP clinical 
Budapest criteria to the included patients, a minority in both cohorts (28% and 27%) did not 
completely meet these criteria currently recommended. However, as the complaints could 
not be explained by any other diagnosis, these patients would nowadays probably be diag-
nosed with CRPS-NOS (not otherwise specified). CRPS-NOS was added as a subtype, next 
to CRPS type 1 (without nerve damage) and type 2 (with nerve damage), to capture patients 
who were diagnosed with CRPS previously and who did not fulfill the criteria anymore (8).
Although both cohorts were similar with regard to gender and age, patients with CRPS 
of the knee had suffered from this condition for a significantly longer time than those with 
CRPS of the ankle/foot. This fact can probably be attributed to physicians’ unfamiliarity 
with diagnosing CRPS of the knee (13). A delay in diagnosing CRPS confined to the knee is 
not uncommon. Katz et al. described an average delay of 29 months (range: 3 weeks to 11 
years) and Cameron et al. described a delay of 26 months before receiving the diagnosis 
CRPS of the knee (10, 14). An average of 11.2 months (range: 3 months to 58.8 months) from 
table 3. Precipitating events for development of CRPS in both cohorts
Knee cohort Ankle/Foot cohort
n (%) n (%)
Event
(Arthroscopic) surgery 15 (30) 14 (21.8)
Arthroscopy 14 (28) 0 (0)
Anterior knee trauma 10 (20) -
Luxation 4 (8) 1 (1.6)
Burns 1 (2) 0 (0)
Fracture 1 (2) 20 (31.3)
Twisting injury 1 (2) 0 (0)
Trauma (inversion, distortion) 0 (0) 16 (25)
Spontaneous 0 (0) 7 (10.9)
Other 4 (8) 6 (9.4)
Total 50 (100) 64 (100)
CRPS, complex regional pain syndrome
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the time of injury to diagnosing CRPS of the knee has been described by Neuschwander 
et al (15). The retrospective design counts as a limitation of this study. Physicians at our 
outpatient clinic may not have recognized the complaints of the knee as CRPS, so the 
symptoms reported and the signs found during clinical examination (and written in the 
patients’ charts) may not give a true picture of the patients’ actual condition.
Significant differences in symptoms and signs between the two cohorts were found 
with regard to four symptoms (hyperesthesia, hyperalgesia, decreased range of motion, 
and dystonia) and four signs (hypoesthesia, hyperalgesia, color asymmetry, and sweat-
ing asymmetry). Although these differences might be due to (not having corrected for) 
multiple testing, (some of) the differences in signs are plausible. Dystonia of the knee 
is uncommon and difficult to examine, because decreased range of motion in the knee 
already influence the flexion and extension of the knee (16). Birklein et al. concluded that 
patients with CRPS have hyperhidrosis in the affected limb, but particularly during the 
acute phase (<2 months) (17). As this retrospective study shows, patients with CRPS of the 
knee suffered longer from this condition. Therefore, by the time the CRPS was diagnosed 
it could already be in a chronic phase. So, an asymmetry in sweating between both knees 
was hard and probably even impossible to objectify.
Because of the significant difference in duration of the disease, and the possibility that 
symptoms and signs of CRPS can differ over time (18), we decided to perform post hoc a 
pairwise matching analysis. We matched the patients based on gender, duration of com-
plaints and age. The range for matching based on duration was within 1 year of complaints 
and the range for matching on age was within 10 years of age; this resulted in 38 pairs of 
patients. Re-analysis yielded no significant difference in gender, age or duration (0.20 ≤ p 
≤ 1.00). Interestingly, after pairwise matching, the significant differences in symptoms and 
signs that we found earlier (when comparing the two complete cohorts) were the same. 
This supports the assumption that CRPS of the knee does differ from CRPS of the ankle/
foot in terms of a few symptoms and signs and that the observed phenotypic variation is 
not due to (possible) inherent changes over time.
The precipitating events differed between both cohorts; patients reported more surgical 
events before development of CRPS of the knee than before development of CRPS of the 
ankle/foot. Earlier reports by O’Brien et al., Katz et al. and Burns et al. confirm this surgical 
cause of CRPS confined to the knee (10, 19, 20).
In conclusion, the phenotypic variation in terms of symptoms and signs of CRPS of the knee 
compared to CRPS of the ankle/foot is limited, but the phenotypes are not identical. We found 
some significant differences between the two cohorts, which probably can be explained by the 
location of the CRPS. The phenotypic variation might be a reason why CRPS in patients with 
pain of the knee, that is disproportionate to the initial trauma, is sometimes not recognized. 
We recommend that physicians add CRPS to their differential diagnosis when encountering a 
patient with pain of the knee that is disproportionate to the precipitating injury.
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aBStRaCt
Objective: Although complex regional pain syndrome (CRPS) of the knee is comparable 
to CRPS of the ankle/foot at time of diagnosis, no reports are available concerning the 
course of knee CRPS. Therefore, this study investigated the clinical course in terms of the 
symptoms and signs, health-related quality of life (HR-QoL), and work status of patients 
diagnosed with CRPS of the knee.
Design: Observational, descriptive study.
Setting: Single-center study.
Subjects: Patients with CRPS of the knee.
Methods: Patients self-reported their past and current CRPS symptoms, HR-QoL and 
work status; all underwent a physical examination. A comparison was made of changes 
in symptoms over time between patients with CRPS of the knee and those with CRPS of 
more distal locations.
Results: In total, 32 patients were enrolled. The follow-up time was 11.5±6.29 years since 
diagnosis, and symptoms and signs showed a significant decrease over time. Twelve 
patients (37.5%) rated their health as (generally) positive. Patients who were still able to 
work (31.3%) stated that their physical health gave them at least some problems in the 
performance of their job. A change in symptoms occurred significantly less often in CRPS 
of the knee.
Conclusions: CRPS of the knee changes in terms of symptoms over time, but significantly 
less than CRPS of other locations. A change in work status was reported in 82% of the 
patients due to their CRPS, and in 91% the pain interfered with their daily life. CRPS of the 
knee is a painful condition with persistent symptoms causing a diminished HR-QoL.
KEy woRdS
Complex regional pain syndrome, knee, course, quality of life, work status
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intRoduCtion
Chronic pain due to complex regional pain syndrome (CRPS) is known to adversely affect 
the life of a patient (1). CRPS is a potentially chronic disease; moreover, continuing pain is 
the most disabling factor for patients and, unfortunately, pain intensity can increase with 
disease duration (2-4).
CRPS confined to the knee is less well known in the medical world (5). The most com-
monly reported initiating trauma for developing CRPS confined to the knee is (arthroscop-
ic) surgery, whereas for CRPS of other locations, fracture is the most reported trauma (6, 
7). We concluded from a previous study that, at the time of diagnosis, the clinical picture 
of CRPS of the ankle/foot (lower limb) is comparable but not identical to that of CRPS 
confined to the knee. In addition, we found a significantly longer duration of disease of 
CRPS confined to the knee before receiving the diagnosis, compared to CRPS of the ankle/
foot (8).
No reports are available on the outcome of CRPS confined to the knee, whereas mul-
tiple studies have investigated the outcome of CRPS of other (more distal) locations. For 
example, Anderson and Fallat investigated a group of 13 patients with CRPS of a lower 
limb with an average disease duration of 3.5 years after diagnosis; of this group, 12 (92%) 
still had continuous pain (9). Others have also found significant pain and impairment in 
patients with CRPS of the lower limb (10); the same applies for patients with CRPS of an 
affected upper limb (11). De Mos et al. concluded that, in their CRPS group, although a 
severe disease outcome was rare, incomplete resolution of all symptoms and signs was 
common (7).
A study on 656 patients with a duration of CRPS of at least one year showed that 81% 
of these patients were no longer able to do their work due to pain at some point after 
diagnosis; of the 81% who stopped working, only 27% resumed their job (4). Others re-
ported a diminished health-related quality of life (HR-QoL) due to disability of the affected 
extremity (2, 12). As no data are available for CRPS confined to the knee, the present 
study aimed to investigate the course of symptoms and signs, HR-QoL and work status of 
patients diagnosed with CRPS confined to the knee. In addition, a comparison was made 
of symptom presentation between patients with CRPS confined to the knee and patients 
with CRPS of a more distal location.
MEthodS
design
This was a single-center, observational, descriptive study.
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Study Population
All patients included in this study were referred to the outpatient pain clinic of our hospital 
during the period 2000-2013. For the purpose of an earlier study, we had already performed 
a manual check of all hospital records of patients with the diagnostic code for CRPS to 
identify patients with CRPS confined to the knee (8). Every patient was seen by the same 
physician (FH), or under direct supervision of this pain specialist. Our institutional ethics 
committee approved a trial we performed at our center (MEC-2014-70) to find patients 
with CRPS confined to the knee, and all patients consented to participate. If a patient was 
diagnosed according to the International Association for the Study of Pain (IASP) clinical 
Budapest diagnostic criteria set (13), they were eligible for inclusion. The IASP clinical 
Budapest diagnostic criteria were adopted in 2010 as the standard for CRPS diagnosis.
To investigate the clinical course of CRPS confined to the knee, a pairwise matched 
analysis was made to compare the course with CRPS of distal locations. Information on 
the clinical course of CRPS of distal locations was collected earlier by De Mos et al. (7); all 
results of this latter study were available at our research center.
Measurements
All patients were asked to visit the department once again to undergo a physical examina-
tion to assess the current signs of their CRPS. The physical examination was performed by 
a physician who has a lot of experience in diagnosing CRPS. Prior to this visit, they were 
asked to answer questionnaires about: 1) their previous and current symptoms of CRPS, 
2) their HR-QoL, 3) their work status, 4) whether they considered their CRPS to be cured or 
stabilized, and 5) whether they experienced sequelae. The questionnaires were completed 
by the patients in advance and were discussed during the visit to avoid missing and/or 
wrong interpretation of their answers. The signs present at the time the patient received 
the diagnosis of CRPS confined to the knee, were collected by inspection of the hospital 
records of each patient.
Statistical analysis
Descriptive statistics were used to determine the frequencies and measures of the central 
tendency of the demographic and outcome parameters. The Kolmogorov-Smirnov test 
was used to analyze whether parameters were normally distributed. For parameters with a 
normal distribution, central tendency and dispersion were described in terms of the mean 
and standard deviation (SD), and parameters with a non-normal distribution in terms of 
the median and interquartile range (IQR). The McNemar test was applied to investigate 
changes that occurred in symptoms and signs.
For all statistics, α was set at the 0.05 level. Data were analyzed using SPSS Statistics, 
version 21 (IBM Corp., Armonk, NY, USA).
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RESultS
A total of 50 patients diagnosed with CRPS confined to the knee were found in the digital 
patient database of our hospital (8). The research physician (CvB) tried to contact every pa-
tient by telephone: five patients were not available, and of the remaining patients, 37 were 
willing to fill in the questionnaires. Eventually, 32 patients returned their questionnaires 
to the outpatient clinic and were included in this study. Within this group, 29 patients gave 
permission to perform a physical examination to assess the current CRPS signs.
demographics
The group of patients diagnosed with CRPS confined to the knee consisted of 28 females 
(88%). At the time of diagnosis, all patients fulfilled the Bruehl and Harden criteria or the 
IASP clinical Budapest criteria. The mean age at the time of this study was 51.2 (SD 15.33) 
years. The mean time since receiving the CRPS diagnosis (SD) was 11.5 (6.29) years. The 
initiating events of the CRPS, as described by the patients, were surgery (44%), some kind 
of trauma (38%), a fracture (6%), and unknown (12%).
Course of CRPS confined to the knee
Table 1 shows the current symptoms and those at the time of diagnosis of the CRPS. 
With the exception of coordination disorder, the relative frequency of all 20 symptoms 
decreased over time; in nine of these, the decrease was statistically significant. Table 2 
shows the CRPS signs at the time of diagnosis and the current signs as measured by physi-
cal examination. An increase in relative frequency was found for allodynia, asymmetry in 
color, hyperalgesia and asymmetry in sweating; however, only the increase in hyperalgesia 
was significant. The relative frequency of the remaining signs decreased.
Of all 32 patients, 31 (97%) reported temperature asymmetry at the time of diagnosis, 
and 28 (88%) at follow-up. In 22 (68%) of these patients, the temperature asymmetry 
remained the same (cold, warm, or alternating hot and cold) and in 10 patients (32%) the 
temperature asymmetry shifted to another status (Table 3). Furthermore, five patients 
(16%) considered their CRPS to be cured, six (19%) patients reported their CRPS to be 
stable, and 27 (84%) experienced sequelae due to CRPS. Of the six patients reporting their 
CRPS to be stable, all experienced sequelae. Of all patients, 17 (53%) were still on medica-
tion and 11 (34%) received physiotherapeutic treatment for the CRPS.
Current work Status
Of all patients, 22 (69%) had a job at the time they were diagnosed; of those patients, 18 
(82%) reported that their work had changed over time due to the CRPS. Of these 18 patients, 
10 (56%) had to stop working, of whom eight patients are still receiving benefits, six (33%) 
changed their job, and the remaining two (11%) adapted their way of performing their job. 
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table 1. Symptoms at time of diagnosis and current symptoms in 32 patients with CRPS confined to the knee
Symptom At diagnosis
n = 32
At follow-up
n = 32
Change
n = 32
p
Yes → No No → Yes
n (%) n (%) n n
Continuous pain 32 (100) 21 (66) 11 0 -
Weakness 32 (100) 27 (84) 5 0 -
Increase after exercise 32 (100) 25 (78) 7 0 -
Hyperesthesia 31 (97) 24 (75) 8 1 0.04*
Decreased range of motion 31 (97) 26 (81) 6 1 0.13
Hyperalgesia 30 (94) 28 (88) 2 0 0.50
Asymmetry in temperature 30 (94) 22 (69) 8 0 0.008*
Asymmetry in color 29 (91) 20 (63) 9 0 0.004*
Swelling 28 (88) 22 (69) 6 0 0.03*
Allodynia 27 (84) 17 (53) 12 2 0.01*
Stiffness 27 (84) 20 (63) 7 0 0.02*
Hypoesthesia 22 (69) 18 (56) 5 1 0.22
Cramp 18 (56) 17 (53) 2 1 1.00
Tingling 17 (53) 12 (38) 5 0 0.06
Involuntary movements 17 (53) 11 (34) 6 0 0.03*
Asymmetry in sweating 15 (49) 8 (25) 7 0 0.02*
Tremor 14 (44) 8 (25) 6 0 0.03*
Asymmetry in hair 14 (44) 11 (34) 3 0 0.25
Asymmetry in nails 11 (34) 10 (31) 3 2 1.00
Coordination disorder 10 (31) 10 (31) 2 2 1.00
*, significant proportional decrease; CRPS, complex regional pain syndr
table 2. Signs at time of diagnosis and current signs in 29 patients with CRPS confined to the knee
Signs at diagnosis
n = 29
Current signs
n = 29
Change of signs
n = 29
p
Yes → No No → Yes
n (%) n (%) n n
Asymmetry in temperature 22 (76) 15 (52) 10 3 0.09
Swelling 19 (66) 17 (59) 8 6 0.79
Decreased range of motion 19 (66) 18 (62) 7 6 1.00
Allodynia 16 (55) 19 (66) 5 8 0.58
Asymmetry in color 10 (34) 13 (45) 4 7 0.55
Motor changes (tremor, dystonia, weakness) 10 (34) 3 (10) 10 3 0.09
Trophic changes (hair, nails) 9 (31) 5 (17) 8 4 0.39
Hyperalgesia 3 (10) 14 (48) 2 13 0.007*
Asymmetry in sweating 0 (0) 1 (3) 0 1 -
*, significant increase; CRPS, complex regional pain syndrome
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Six patients have filed a claim for a work-related injury with their employer. Of those, one 
claim has been settled, whereas the others are pending. At the time of this study, the 10 
patients that had a job were asked additional questions about their ability to perform their 
job. Eight reported that their physical health gave some, or major, problems in performing 
their job due to CRPS. The most frequently reported reason for this was decreased range 
of motion of the knee.
Current Quality of life
All 32 patients with CRPS confined to the knee were asked to rate their health; six (19%) 
rated their health as poor, 14 (44%) as fair, nine (28%) as good, and three (9%) as very 
good. Of all patients, 28 (88%) reported that their health status caused limitations in 
performing moderate or more demanding activities (e.g. moving a table) and 29 patients 
(91%) reported that the pain interfered with their daily life. In addition, almost 50% of the 
patients stated that, as a result of emotional problems, they experienced difficulties with 
their work or (other) regular daily activities (Table 4).
Comparison of knee CRPS and other CRPS
Patients with CRPS confined to the knee were pairwise matched (based on disease du-
ration) with patients with CRPS of distal locations (hand/wrist/ankle/foot) to compare 
changes in the relative frequency of symptoms over time between the groups. For this 
analysis, we matched 24 patients from each group. The results show that, in terms of the 
defined symptoms, CRPS confined to the knee showed less change over time compared to 
CRPS of distal locations: that is, of the 20 symptoms, only four showed a significant change 
in patients with CRPS confined to the knee, compared with 11 in patients with CRPS of 
distal locations (Table 5).
table 3. Patients with CRPS confined to the knee (n=32) who did/did not show change in type of tempera-
ture asymmetry
Change in temperature asymmetry over time
Warm Cold Variable No difference Temperature at
time of diagnosis
n (% ) n (%) n (%) n (%) n (%)
Warm 9 (28) 5 (16) 1 (3) 2 (6) 17 (53)
Cold 0 9 (28) 0 1 (3) 10 (31)
Variable 0 1 (3) 3 (9) 0 4 (13)
No difference 0 0 0 1 (3) 1 (3)
Current temperature asymmetry 9 (28) 15 (47) 4 (12.5) 4 (12.5) 32 (100)
CRPS, complex regional pain syndrome
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diSCuSSion
The aim of this study was to investigate the course of CRPS confined to the knee in terms 
of symptoms and signs, self-reported HR-QoL, and the work status of patients diagnosed 
with this disorder. This study was performed due to the absence of earlier reports on this 
specific topic.
In our patients, a self-reported recovery rate of 16% was found after a mean follow-up 
of 11.5 years, compared with the 29% reported by de Mos et al. (7). However, in the latter 
study, follow-up was only 5.8 years and, in contrast to our sample, their 102 patients were 
diagnosed with lower/upper limb CRPS. Although spontaneous resolution did not occur 
in our patients with knee CRPS, this has been described previously (14-16); however, in 
these latter studies, most patients had CRPS of the upper extremity. In our group, only 
one patient was free of symptoms and signs, but this was after extensive treatment. Some 
significant changes in symptoms were found in our patients at follow-up, mostly based on 
a decrease in presentation. Regarding possible changes in signs, we found a significant 
increase in presentation only for hyperalgesia. Therefore, although our patients experi-
table 4. Frequency of answers of patients diagnosed with CRPS confined to the knee (n=32) regarding their 
quality of life (QoL)
Current quality of life (Qol) frequency (n)
Excellent Very good Good Fair Poor
Health in general 0 3 9 14 6
Yes, a lot Yes, a little No, not at all
Health limits in:
Moderate activities
Climbing flights of stairs
21
20
7
9
4
3
Yes No
Physical health:
Accomplished less
Limited in activities
26
27
6
5
Emotional problems:
Accomplished less
Limited in activities
15
13
17
19
Not at all A little bit Moderately Quite a bit Extremely
How much did pain interfere 3 6 6 8 9
All of the 
time
Most of 
the time
A good bit of 
the time
Some of the 
times
A little of the 
time
None 
of the 
time
Felt calm and peaceful 1 7 7 14 3 0
Had a lot of energy 1 4 6 14 6 1
Felt downhearted and blue 0 3 3 10 8 8
Interference with social activities 5 12 0 9 1 5
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enced a subjective recovery of CRPS or a reduction in symptoms, the objective signs did 
not show a significant decrease, that is, the subjectively experienced improvement could 
not be objectified. As there are no earlier reports on the clinical course of CRPS confined 
to the knee in terms of symptoms and signs, no comparison could be made between our 
results and other studies.
Currently, the diagnosis of CRPS is still based on symptoms and clinical signs, and no 
additional measurements are needed. So, a physician needs a significant amount of 
experience in diagnosing CRPS. The clinical examination in our patients was done by an 
experienced physician. Still, we figure this to be a limitation of diagnosing patients with 
CRPS and also a limitation of this study. The CRPS Severity Score (CSS) may be a helpful 
tool for monitoring the course of CRPS and outcomes research (17). We did use the CSS at 
the time of the study, but unfortunately, it was not used at the time the patients received 
their diagnosis of CRPS. We would like to add the CSS in future research at our center.
table 5. Changes in symptom presentation in both groups after matching duration of disease
Symptom
Change in Knee CRPS group
n = 24
p Change in Distal CRPS group
n = 24
p
n (%) n (%)
Continuous pain 9 (38) - 15 (63) <0.001*
Allodynia 8 (33) 0.02* 14 (58) <0.001*
Asymmetry in color 7 (29) 0.02* 15 (63) <0.001*
Hyperesthesia 7 (29) - 6 (25) 0.07
Asymmetry in temperature 6 (25) 0.03* 11 (46) 0.001*
Asymmetry in sweating 5 (21) 0.06* 7 (29) 0.02*
Increase after exercise 5 (21) - 4 (17) 0.22
Stiffness 5 (21) 0.06 3 (13) 0.38
Decreased range of motion 4 (17) 0.22 9 (38) 0.004*
Swelling 4 (17) 0.25 15 (63) <0.001*
Tremor 4 (17) 0.13 1 (4) 1.00
Weakness 4 (17) - 6 (25) 0.07*
Hypoesthesia 3 (13) 0.25 4 (17) 0.22
Tingling 3 (13) 0.25 4 (17) 0.13
Involuntary movements 3 (13) 0.25 1 (4) 1.00
Asymmetry in hair 1 (4) 1.00 7 (29) 0.02*
Asymmetry in nails 1 (4) 1.00 7 (29) 0.02*
Hyperalgesia 1 (4) 1.00 8 (33) 0.01*
Cramp 0 (0) 1.00 3 (13) 0.25
Coordination disorder 0 (0) 1.00 2 (8) 0.50
*, significant difference; CRPS, complex regional pain syndrome
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Based on the pairwise matched analysis, the symptoms of CRPS confined to the knee 
were more stable over time compared to CRPS of more distal locations, and recovery was 
less common. However, due to multiple testing, our study may have been at increased risk 
of a type 2 error; this implies that some statistical tests may have incorrectly resulted in 
significance. Nevertheless, as reported earlier, the diagnosis of CRPS confined to the knee 
seems problematic; for example, it took longer (possibly due to phenotypic variation) 
before a diagnosis of CRPS was made (8). This can lead to a potential delay in starting the 
appropriate treatment and, subsequently, to a more stable course in terms of symptoms 
(i.e. a significantly reduced decrease in reported symptoms). This corresponds to earlier 
reports stating that earlier recognition and treatment result in potentially better outcome 
in patients with CRPS (18).
Patients with cold CRPS at the time of diagnosis are reported to have a poorer clinical 
pain outcome (19). In our patients diagnosed with CRPS confined to the knee, 11 (34%) 
started with cold CRPS, of whom five reported that their continuous pain resolved over 
time. On the other hand, 17 patients (53%) started with warm CRPS, and at the time of this 
study, five reported that they no longer had continuous pain. Therefore, for this patient 
group, we cannot confirm the poorer clinical pain outcome based on the temperature 
at diagnosis. A possible explanation for this could be that, as shown in this study, CRPS 
confined to the knee has a limited change in symptoms over time compared to other 
more distal locations. In 10 of our patients, the temperature asymmetry changed based 
on the symptoms. This self-reported temperature shift could imply that physicians should 
change their treatment strategy based on the possible underlying mechanisms, to achieve 
a better outcome for patients diagnosed with CRPS (20, 21).
Patients with CRPS confined to the knee appear to have reduced HR-QoL, similar to pa-
tients with CRPS in more distal locations. For example, van Velzen et al. described patients 
with lower limb CRPS who reported poor HR-QoL; they also found a negative correlation 
between disease duration and physical functioning. In line with this finding, they reported 
that the HR-QoL of patients is best explained by the impact of CRPS on their physical 
health (12). Kemler and de Vet reported that the HR-QoL of patients with chronic reflex 
sympathetic dystrophy (RSD, a term earlier used to describe CRPS) of the leg was affected 
due to CRPS (10). In addition, Galer et al. concluded that persistent CRPS symptoms after 
a mean disease duration of 3.3 years substantially interfered with patients’ health-related 
quality of life and daily functioning (22).
In the present study, there was a change in the work status of 82% of our patients diag-
nosed with CRPS confined to the knee. This is in line with Kemler and Furnee, who found 
that in 72% of their patients, the work status changed due to the CRPS (1). Dumas et al. 
found that lower limb involvement was significantly negatively correlated with return to 
work (23). In contrast, Duman et al. reported a return to work ability of 72% (24); surpris-
ingly, this latter group consisted solely of male patients, whilst mostly female patients are 
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diagnosed with CRPS (15, 25). In our group of patients, 80% reported that their physical 
health gave them problems in performing their job. This is in line by other reports that 
CRPS interferes with functional activity and the ability to (resume) work (22). In contrast, 
two studies reported that 68% and 72% of their patients with CRPS of the upper limb re-
sumed their work (23, 24). Also, CRPS of the lower limb led to difficulties in social activities 
and work compared with patients with an affected upper limb (10).
Furthermore, Thevenon et al. described that patients with CRPS affecting an upper limb 
needed longer treatment and had longer work absence than patients with CRPS affecting 
a lower limb (26). A study on 656 patients (after a duration of CRPS of at least one year) 
showed that 81% of these patients were no longer able to do their work due to pain at 
some point after diagnosis; of the 81% who stopped working, only 27% resumed their job 
(4).
In conclusion, this study was performed to investigate the course of CRPS confined to 
the knee. Since this is the first study to provide information on the clinical course of this 
specific CRPS location, no comparison can be made with other studies. Despite a decrease 
in symptom presentation, most of our patients had persistent symptoms and signs at a 
mean of 11.5 years after initial diagnosis, and only a minority returned to their original 
work. Compared to CRPS of more distal locations, CRPS confined to the knee shows 
significantly less change in terms of symptoms. Most of our patients reported to have 
sequelae, and only five (16%) considered themselves to be cured. Also, the pain continued 
to interfere with their daily activities.
In summary, CRPS confined to the knee is a painful condition with a less favorable clini-
cal course than CRPS of more distal locations, including an adverse impact on work status 
and a diminished HR-QoL, which could potentially lead to high socioeconomic costs.
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aBStRaCt
Objectives: To report on the efficacy of dorsal root ganglion (DRG) stimulation in a patient 
with complex regional pain syndrome (CRPS) type I of the knee.
Materials and Methods: A 48-year-old woman with CRPS type I of the right knee, diag-
nosed according to the Budapest criteria set, received DRG stimulation for intractable 
CRPS type I of the knee.
Results: After a successful trial period with three DRG stimulation leads on spinal levels L2, 
L3 and L4 (covering 90% of the painful area of her knee), a definitive pulse generator was 
implanted. Three months after implantation, the entire painful was area covered and the 
patient reported a numeric rating scale score of 1-2.
Conclusion: Placement of three DRG stimulation leads at levels L2, L3 and L4 in a patient 
with intractable CRPS type I of the knee resulted in major pain relief. We recommend 
further investigation of the effect of DRG stimulation on pain due to CRPS of the knee.
KEywoRdS
Complex regional pain syndrome type I, dorsal root ganglion stimulation, knee, numeric 
rating scale, numeric rating scale, treatment
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intRoduCtion
Complex regional pain syndrome (CRPS) is a collection of locally appearing painful condi-
tions that mainly occur distally and exceed in both intensity and duration the expected 
clinical course of the original trauma. In a minority of patients, the condition is restricted 
to the knee. Recently, a systematic review was performed to find evidence for the diag-
nosis of CRPS of the knee. The authors concluded that this diagnosis has been described 
before and the best therapy is yet to be found (1).
Dorsal root ganglion (DRG) stimulation is an effective and safe stimulation technique, 
and previous reports have implicated the DRG in the development and persistence of 
chronic pain. The ganglion houses cell bodies of primary sensory neurons, including cells 
that transmit pain information to the central nervous system (2). Deer et al. reported the 
successful use of DRG stimulation in 10 patients with chronic, intractable neuropathic pain 
of the trunk and/or limbs. These patients received DRG stimulation for 3-7 days. All patients 
experienced pain relief in the targeted anatomical regions, with reported improvement 
ranging from 17% to 100%(3). Liem et al. reported on 32 patients with pain of the back, 
leg, and foot treated with DRG stimulation; at 6 months after implantation, ≥ 50% of the 
patients had 50% or more pain relief (4).
The above-mentioned favorable results of DRG stimulation of body parts other than 
the extremities led us to stimulate the DRG in a patient with CRPS type I of the knee that 
appeared to be intractable.
CaSE REPoRt
history
We retrospectively present a case of CRPS in a 48-year-old woman who suffered com-
plaints of the right knee for five years. One week after a diagnostic arthroscopy to rule out 
any meniscal problem, she developed CRPS type I of the knee. This patient was referred 
to our department for a second opinion. She had already been extensively treated with 
different types of oral medication. In addition, a lumbar sympathetic block resulted in no 
clinically significant relief of symptoms, and physical therapy also failed. In particular, the 
patient’s pain (reported to be the most disabling factor) did not decrease.
Examination
When the patient visited our department, the pain on the lateral side and within the knee 
was described as “irritable and aching” with a score of 6-9 on a numeric rating scale (NRS) 
ranging from 0 (“no pain”) to 10 (“extremely painful”). In addition, she experienced al-
lodynia, hyperalgesia, and tingling around her right knee. The sensory symptoms were not 
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limited to the innervation area of a single nerve. She also mentioned discoloration of the 
whole knee, a colder temperature compared to the left knee, trophic changes in leg hair, 
and motoric dysfunction, but no sweating changes or edema.
Physical examination revealed a swollen, cold, and dark-colored right knee. Palpation 
was very painful, especially around the patella and the medial tibia head. Allodynia 
and hyperalgesia around the whole knee and movement restriction also were present. 
Exploratory neurological examination revealed no other signs as the earlier-mentioned 
sensory disturbances. The area of the sensory disturbances could not be explained by a 
mono neuropathy or other neurological etiology. We confirmed the diagnosis CRPS type 
I of the knee, based on the Budapest criteria set. In addition, thermography revealed the 
right knee to be colder compared to the left knee.
treatment
Our treatment started with different types of oral medication, followed by ketanserin/
carnitine intravenously. None of these provided any relief of her symptoms; the allodynia 
even became worse and edema developed. Therefore, we considered neurostimulation as 
a treatment. In view of the limited area involved and of earlier experience in our depart-
ment of disappointing results with dorsal column stimulation in patients with comparable 
localized CRPS, we decided to apply DRG stimulation and included her in a medical ethical 
committee-approved observational study in our department for the use of DRG stimula-
tion. The patient was informed and gave written consent.
dRg stimulation
The DRG was approached in the same way as described by Liem et al. (4) We implanted 
three DRG stimulation leads at spinal levels L2, L3, and L4, at the right side of the spine 
(Fig. 1).
The treatment started by implanting one DRG stimulation lead at spinal level L3. The 
patient reported stimulation vibes within her knee, but these did not cover the entire area. 
A second DRG stimulation lead was implanted at level L4. The stimulation now covered 
more of the painful area, but still not everything. So we tried a third DRG stimulation lead 
on level L2. This level was chosen because of earlier experience with DRG stimulation in 
our department: sometimes the best level for DRG stimulation is above or below the level 
one would expect based on the dermatome map. After implantation of this third lead, the 
stimulation covered almost the entire area; only one spot on the lateral knee side was not 
covered.
When one lead was in place, it was connected to an external neurostimulator. The 
neurostimulator was programmed to ensure that the paresthesias were directed to the 
correct location; the same procedure applies to the other two leads. The parameters of 
stimulation are presented in table 1.
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After eight days of stimulation coverage, the patient reported a substantial decrease in 
pain intensity. One spot on the lateral knee side was still not covered, but she was very 
pleased with the results and requested to proceed with permanent implantation. Before, 
she scored the pain as NRS 6-9, whereas now she scored it as 1. One week later, the im-
plantable pulse generator was placed in the patient’s left buttock (Fig. 2).
figure 1. Dorsal root ganglion stimulation leads 
with four electrical contacts at levels L2, L3, and L4
table 1. Parameters of dorsal root ganglion stimulation in a 48-year-old female patient
Lead 1
(Spinal level L2)
Lead 2
(Spinal level L3)
Lead 3
(Spinal level L4)
Electrode configuration 1 N - N
(+, - or N) 2 N N N
3 + + +
4 - N -
Pulse width (µsec) 170 170 160
Frequency (Hz) 20 20 20
Amplitude (µA) 700 1030 500
+, positive; -, negative; N, neutral
figure 2. Implantable pulse generator placed 
in the left buttock
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One month post-implant, she stated that the entire painful area was covered and graded 
her pain as 1-2 during stimulation. In addition, movement of the right knee had improved. 
The device was used 24 hours a day. At 3-months follow-up the NRS score was still 1-2 
during stimulation. She did not feel the stimulation vibes anymore, but she certainly could 
tell when the device was switched off, as her pain returned within minutes. On the other 
hand, when it was switched on, the effect kicked in within one minute. The patient will 
further be periodically monitored over one year.
diSCuSSion
This patient with CRPS type I of the knee failed to respond to multidisciplinary pain man-
agement. The symptoms fit the Budapest criteria set, but infrapatellar nerve injury should 
be considered as differential diagnosis (5). An electromyography was not performed, so 
we cannot be 100% sure that there was no demonstrable nerve damage. In case of nerve 
damage, the diagnosis should be CRPS type II. The DRG stimulation therapy resulted in 
a clinically significant result: the pain level dropped from an initial NRS score of 9 to 1-2 
and the movement of the knee became better. We chose DRG stimulation due to earlier 
experience in our department with CRPS of the knee: most patients barely respond to con-
servative treatment and dorsal column stimulation. Our first results with DRG stimulation 
therapy for CRPS of the knee are promising and in line with others (3, 4). However, none 
included a patient with CRPS of the knee. In addition, our follow-up was three months 
whereas that of Liem et al. (4) was six months, making it difficult to extrapolate their re-
sults to ours. We realize that this is a case report and therefore had limitations concerning 
the generalizability across patients; nevertheless, we consider the present results to be 
encouraging and the DRG to be a potential new neural target for reducing chronic neuro-
pathic pain due to CRPS of the knee.
ConCluSion
This report indicates DRG stimulation to be an effective therapy for reducing chronic 
neuropathic pain due to CRPS of the knee. Stimulating the DRG covered the entire painful 
area, and up to three months post-implant the initial NRS score of 9 had decreased to 1-2. 
Long-term results are not yet available, and more patients with similar complaints need to 
be investigated. If such studies replicate the present findings, a controlled study should be 
performed in order to draw more definite conclusions.
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aBStRaCt
Background and Objectives: Patients with complex regional pain syndrome (CRPS) con-
fined to the knee are often therapy resistant. Neurostimulation is an accepted treatment 
for CRPS. Although results with dorsal column (DC) stimulation in patients with CRPS 
confined to the knee are often disappointing, the availability of dorsal root ganglion (DRG) 
stimulation may provide new opportunities for this complaint. Therefore, this study ex-
plores patients’ preference for DC stimulation versus DRG stimulation in treating chronic 
pain due to CRPS confined to the knee.
Methods: A prospective, observational crossover cohort study was conducted comparing 
2 methods of neurostimulation, in randomized order, in patients with CRPS confined to 
the knee. After receiving DC and DRG stimulation during a trial period of 16 days, patients 
were asked which of the 2 methods they preferred. Patients with a successful trial period 
with one or both stimulation methods received a fully implantable system.
Results: Twelve patients were included. After finishing the trial period, 10 patients (83.3%) 
preferred DRG stimulation and 2 (16.7%) preferred DC stimulation (P = 0.04).
Conclusion: To our knowledge, this is the first study to compare these 2 neurostimulation 
methods in patients with CRPS confined to the knee. Results show that the probability of 
the preference for either neurostimulation treatment significantly deviates from chance in 
favor of DRG stimulation.
KEywoRdS
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intRoduCtion
Complex Regional Pain Syndrome (CRPS), formerly known as reflex sympathetic dys-
trophy (RSD) or algodystrophy, is a collection of locally appearing painful conditions 
following a trauma. Although CRPS mainly occurs in the feet or hands, other locations are 
also reported (1). CRPS exceeds in both intensity and duration the expected course of the 
original trauma. The main clinical features are continuing pain and sensory, vasomotor, 
sudomotor, and motor trophic disturbances (2). CRPS is a clinical diagnosis based on signs 
and symptoms described in criteria sets. Currently, the use of the International Associa-
tion for the Study of Pain (IASP) clinical Budapest diagnostic criteria is recommended (3). 
The natural history of CRPS is not always positive and can result in permanent disability.
Until now, little has been known about patients with CRPS confined to the knee. In a 
systematic review, we concluded that CRPS confined to the knee should be considered 
as a separate phenotype, distinct from CRPS of more distal locations (4). In addition, 
uncertainty remains regarding the best treatment for CRPS confined to the knee (4). In 
the Netherlands, all patients with CRPS are treated according to the Dutch Guidelines (5) 
(updated in 2014). However, as earlier literature shows, patients diagnosed with CRPS 
confined to the knee are difficult to treat (6-8).
Dorsal column (DC) stimulation is an accepted, effective and safe way of treating specific 
types of neuropathic chronic pain. In the Netherlands, driven by reimbursement policies, 
this therapy is used as a last resort for patients in whom the more conservative treatment 
(eg, oral pain medication) has failed. The presumed mechanism of action is based on 
electrical stimulation of the large ascending fibers located in the dorsal columns (A beta-
fibers), which leads to inhibition of the nociceptive signal entering the spinal cord through 
the dorsal root (A delta- and C-fibers). CRPS is the second most common indication for DC 
stimulation, failed back surgery syndrome being the first (9). DC stimulation can provide 
evident and clinically relevant pain reduction in patients with CRPS (10-14).
The dorsal root ganglion (DRG) is a different target for neurostimulation. The DRG plays 
a pivotal role in the development and maintenance of chronic pain (15). The ganglion 
houses the cell bodies of primary sensory neurons, including those cells that transmit 
pain information to the central nervous system (15). In 2011, the first patients received 
DRG stimulation for their chronic neuropathic pain. After 12-month follow-up, patients 
experienced improvement in pain symptoms, health-related quality of life, and their 
mood (16). In a prospective case series by van Buyten et al., 8 patients with CRPS of the 
lower extremities received DRG stimulation after a successful trial period. Follow-up of 12 
months showed improvement in quality of life in all patients and a reduction in pain ≥50% 
compared to baseline in 6 of the 8 patients (P < 0.05) (17).
Our department has experienced both the failures and successes of DC stimulation in 
several patients diagnosed with CRPS confined to the knee. When DRG stimulation be-
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came available, 1 patient with CRPS confined to the knee was successfully treated using 
this method (18); this result gave rise to the present study. Based on our hypothesis that 
DRG stimulation would be more specific than DC stimulation, we compared both methods 
of neurostimulation in patients with CRPS confined to the knee.
The aim of this trial was to explore patients’ preferences in treatment by neurostimula-
tion of their chronic neuropathic-like pain due to CRPS confined to the knee.
MEthodS
The institutional research ethics committee approved this study (MEC-2014-170).
design
This was a prospective, observational, crossover, cohort study comparing 2 methods of 
neurostimulation, that is, DC and DRG stimulation in randomized order. All patients were 
diagnosed with CRPS confined to the knee according to the IASP clinical Budapest diag-
nostic criteria (3) and received (in randomized order) both methods of neurostimulation 
in succession during a trial period of 16 days in total. During this period, all patients were 
asked to keep a diary in which they registered their pain intensity on a visual analog scale 
(VAS) 3 times a day (19). After the trial period, all patients were asked to state which stimu-
lation method they preferred as treatment. The study was registered at www.trialregister.
nl (NTR5662).
Study population
Patients diagnosed with CRPS confined to the knee who visited the outpatient pain clinic 
were invited to participate. To be included, a patient had to meet all the following inclu-
sion criteria: ≥1 year of CRPS confined to the knee; diagnosed according to the IASP clinical 
Budapest diagnostic criteria; minimum age of 18 years; no improvement in symptoms 
after ≥1 year of treatment according to the Dutch guidelines for CRPS (updated in 2014) 
(5); and a pain intensity of ≥50 mm measured on a VAS of 0 to 100 mm. Table 1 presents the 
inclusion/exclusion criteria.
intervention
Neurostimulation methods are fully implantable medical devices which are placed epidur-
ally and produce controlled electrical stimulation to spinal neural tissue. For this study, in 
randomized order, using a crossover design, we applied DC stimulation (Medtronic Inc.®; 
Fridley; MN, USA) with one 8-contact lead, and DRG stimulation (St. Jude Medical Inc.®; 
Little Canada; MN, USA) with two 4-contact leads.
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Following patient consent and study entry, baseline measurements were made (T0). 
Patients used the 2 neurostimulation methods during the trial period, which lasted 16 
days in total. On day 1, implantation of the stimulation leads of both methods took place. 
A qualified physician with extensive experience in implantation of DC and DRG stimulation 
systems (F.J.P.M.H.) implanted (under local anesthesia) one 8-contact lead for DC stimula-
tion and two 4-contact leads for DRG stimulation at the same time, during the same pro-
cedure. All leads were sutured to the fascia with soft tissue anchors, and the external lead 
exit point was protected with a bandage.
During the first week, patients received stimulation method 1 (T1); between the 2 
stimulation methods, a washout period of 2 days was included (ie, a period without any 
stimulation, T2); during the second week, patients received stimulation method 2 (T3). A 
randomization based on a computer program decided the order of stimulation. A qualified 
nurse took care of turning on the stimulation method, of securing the right settings (DC 
stimulation was set between 30 and 60 Hz), and of the evaluations during the trial period 
based on the patients’ report and diaries.
The effect of either stimulation method was considered successful if the patient re-
ported at least 50% reduction of pain compared to the situation just prior to that method 
of stimulation and/or at least a slight improvement on the global perceived effect (GPE) 
scale (20) after that stimulation. When one of the stimulation methods was considered 
successful, the patient was eligible to continue treatment with that stimulation method. In 
case both of the stimulation methods were considered successful, the patient was allowed 
to choose the stimulation method he or she preferred.
A second surgical procedure, under general anesthesia, took place on day 16 of the trial 
period. A qualified physician (F.J.P.M.H.) implanted an implantable pulse generator (IPG) 
table 1. Inclusion and exclusion criteria for participation in the study
inclusion criteria Exclusion criteria
Over 1 year CRPS confined to the knee, diagnosed 
according to the IASP clinical Budapest diagnostic 
criteria
Previous neurostimulation
Depression or anxiety disorder measured with the 
Hospital Anxiety and Depression Scale (HADS)
Pregnancy, or pregnancy desire within 1 year
Minimum age 18 years Patients unable to complete the questionnaires
No improvement of symptoms after at least 1 year of 
treatment according to the Dutch guidelines for CRPS 
in primary care
Body Mass Index > 35
Life expectancy < 1 year
Implantable cardioverter defibrillator, pacemaker
Pain intensity of at least 50 mm measured on a visual 
analog scale 0-100 mm
Anticoagulant drug therapy or disturbed coagulation
Immunocompromised patients
Drugs/medication/alcohol addiction
CRPS, complex regional pain syndrome; IASP, international association for the study of pain
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in the abdomen or buttock of the patient for the lasting stimulation and removed the leads 
of the other system. Patients then entered the long-term follow-up period of 12 months. 
In case both stimulation methods failed, both were explanted during the second surgical 
procedure. During the 12-month follow-up period, patients visited the pain department at 
1, 3, 6 and 12 months after the second surgery.
Statistical analysis
The primary outcome parameter was the patient’s preference for one stimulation method 
over the other, being a binomial variable. As this was an explorative study, the aim of the 
statistical analysis was primarily descriptive, not inferential. The proportion of patients 
preferring one stimulation method over the other will be reported, including the 95% 
confidence interval (CI) of that proportion (Clopper-Pearson Exact method). Analyses were 
performed using IBM SPSS Statistics 21 (IBM Corp. Armonk. NY, U.S.A).
RESultS
Of the 74 patients considered for inclusion, 60 were excluded because 1) the diagnosis 
CRPS of the knee could no longer/not be confirmed, 2) they had already received treat-
ment with neurostimulation, or 3) they were unwilling to participate. Of the remaining 
14, 1 patient dropped out during the first operational procedure. In this patient, it proved 
impossible to implant the two 4-contact leads of the DRG stimulation, possibly due to 
degenerative deviations in the lumbar spine. Another patient dropped out during the 
trial period because he experienced sensory complaints in both legs the day after the first 
operational procedure. The sensory complaints were not objectivized by a neurologist, 
and an infection or epidural bleeding was ruled out. However, to reduce any potential risk 
of damage, the leads of both systems were removed shortly thereafter; the complaints 
disappeared immediately after removal and no permanent injury occurred.
This left 12 patients who finished the entire trial period: 11 females, 1 male; mean age 
38.7 (range 22 to 57) years. In this group, mean VAS score at baseline was 68 on a scale of 
0 to 100 (0 representing no pain, 100 representing worst imaginable pain). None of the 
included patients had demonstrable nerve injury in the affected knee (as measured by 
an electromyogram). Coverage of the painful area during implantation, was achieved in 
every patient with placement of the DC stimulation lead at the 8th, 9th or 10th thoracic ver-
tebra (Th-8, Th-9 or Th-10) and placing the DRG stimulation leads at the 3rd and 4th lumbar 
vertebrae (L-3 and L-4). Figure 1 shows the lead placement in a representative patient: 
the DC stimulation lead tip was positioned at Th-10 and the DRG stimulation leads were 
positioned at L-3 and L-4.
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Patients’ Preference
Ten patients (83.3%) preferred DRG stimulation and 2 [16.7%; (95% CI: 0.02 to 0.48)] pre-
ferred DC stimulation (P = 0.04, one-sample binomial test).
figure 1. Lead placement during trial period
Th-10, 10th thoracic vertebra; L-3/L-4, 3rd and 4th lumbar vertebrae
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In 5 patients, both stimulation methods were considered successful (patients 2, 4, 10, 
11, and 13). These patients were allowed to decide which stimulation method they would 
have implanted permanently. Four patients (2, 4, 10 and 13) chose the DRG stimulation. 
Their main reason for this was that (in contrast to DC stimulation) they felt no stimulation 
vibrations. Moreover, during the evaluation of DC stimulation, all mentioned that they had 
to adjust the stimulation intensity multiple times a day. One of these patients also chose 
DRG stimulation because DC stimulation did not cover the whole painful area. In contrast, 
patient 11 chose DC stimulation because she liked the fact that she felt the stimulation 
vibrations and found that her walking ability had improved more with DC stimulation.
For all 12 patients, the stimulation method they preferred was implanted during the 
second surgical procedure.
the implanted method
In 7 of the 12 patients, the decision regarding which stimulation method was to be 
implanted was based on the fact that only one stimulation method proved successful 
after completing the trial period (patients 1, 3, 6, 7, 9, 12, and 14). The 4 patients who 
had success with only DRG stimulation stated that the vibrations of DC stimulation were 
intermittent to intensive and rather nonspecific (ie, the area covered by stimulation was 
larger than the painful area alone) or did not stimulate the actual painful area. The patient 
in whom only DC stimulation worked stated that DRG stimulation provided no pain relief, 
and no improvement was experienced in relative to the baseline GPE score.
Measurements during the trial
During the trial period, patients returned to our department 3 times. At each visit, the 
nurse turned on/off the stimulation method and made an evaluation based on the pa-
tient’s self-report and diary. Mean VAS scores were calculated for each stimulation method 
based on the 3 scores in the patient’s diary on the last day of stimulation with that method. 
Using the GPE scale, patients were asked at T1 and T3 to rate how much their condition 
had changed in comparison with T0 and T2, respectively. All patients responded that their 
condition had (much) improved and that they were (absolutely) satisfied with the result 
based on their preferred stimulation method. Table 2 presents these data.
adverse Events
During the trial period, 3 adverse events were experienced by 2 patients; these were judged 
by the investigators to be related to the device or to the surgical procedures. One patient 
had cerebrospinal fluid leak with associated headache after the first surgical procedure; in 
this patient, all leads were removed during the second surgery, due to possible infection, 
and 3 months later, the device of choice (ie, DRG stimulation) was implanted. Another pa-
tient was admitted to hospital for a few days because of elevated temperature; however, 
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no active infection was demonstrated on blood tests. The patient with sensory complaints 
in both legs 1 day after the first procedure was excluded from the study; nevertheless, this 
patient was reported as experiencing an adverse event, possibly related to the device. The 
sensory complaints were not objectivized by a neurologist, and an infection or epidural 
bleeding was ruled out.
diSCuSSion
The aim of this prospective trial was to explore patients’ preference in treatment by 
neurostimulation of their chronic neuropathic-like pain due to CRPS confined to the knee. 
In a crossover design, DC stimulation was compared with DRG stimulation. The results 
show that, in these patients, the probability of the preference for either neurostimulation 
treatment significantly deviates from chance in favor of DRG stimulation.
dC vs. dRg stimulation
Reduction in pain due to DC or DRG stimulation turned out to be comparable between 
the patients, as shown in table 2. So, apparently, patients have other, probably individual, 
reasons to prefer a stimulation method, and this is not solely based on obtained pain 
table 2. Scores on the VAS and GPE, and patients’ preference during the trial period
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1 82 DRG 71 No change 83 DC 32* Much improved* DC
2 76 DRG 10* Much improved* 78 DC 0* Much improved* DRG
3 85 DC 54 Slightly improved* 70 DRG 33* Slightly improved* DRG
4 70 DC 0* Completely recovered* 35 DRG 0* Completely recovered* DRG
6 74 DRG 49 Slightly improved* 82 DC 78 No change DRG
7 50 DC 24* No change 31 DRG 11* Slightly improved* DRG
9 70 DRG 21* Slightly improved* 65 DC 51 Slightly improved* DRG
10 85 DRG 36* Slightly improved* 90 DC 51 Slightly improved* DRG
11 71 DC 3* Much improved* 80 DRG 16* Much improved* DC
12 75 DC 49 No change 46 DRG 67 Slightly improved* DRG
13 80 DC 43 Slightly improved* 67 DRG 35 Much improved* DRG
14 63 DC 67 No change 61 DRG 30* Much improved* DRG
VAS, visual analog scale; GPE, global perceived effect scale; DRG, dorsal root ganglion; DC, dorsal column. 
*Trial success
T0, baseline; T1, after stimulation 1; T2, after washout period; T3, after stimulation 2
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relief. This finding is in line with the results found by others (21). DC stimulation is known 
to be somewhat nonspecific and to have more positional side-effects (22). In this study, 
both these items were often mentioned by patients as reasons for their preference for DRG 
stimulation over DC stimulation. Three patients stated that DC stimulation did not cover 
the entire painful area. In contrast, 4 patients reported that DC stimulation covered an 
area that was actually larger than their painful area. During evaluation of DC stimulation, 
6 patients said that they thought the stimulation vibrations were too strong, even after 
lowering the intensity themselves. They also mentioned they found it bothersome to 
have to adjust the stimulation level several times a day, as well as experiencing different 
stimulation intensities during walking, sitting, or lying down. Therefore, the present study 
confirms that DC stimulation can be rather nonspecific and has more positional side ef-
fects. None of these limitations were mentioned in relation to DRG stimulation and were 
reasons for patients to prefer that form of stimulation.
In one patient, it was impossible to implant the DRG leads, whereas the DC stimulation 
lead was placed in the right position without any problem. A computerized axial tomo-
graphic scan showed a degenerative lumbar spine, but no neuroforaminal stenosis. Thus, 
even when the neuroforamina appear to have a normal entry, it can be difficult to place 
DRG leads, in our case possibly due to degeneration of the lumbar spine. This can be an 
important item when considering the feasibility of applying DRG stimulation. Also, in 2 of 
the patients, motor stimulation occurred when stimulating one of the DRG leads. Adjust-
ing the settings turned out to be the solution to remove the motor stimulation. This motor 
stimulation did not occur with DC stimulation.
Methodological Remarks
The trial period included a washout period of 2 days; there are no earlier reports concern-
ing the appropriate duration of a washout period. At T2 (after the washout period), all 
patients reported that the pain relief ceased within minutes to hours after stopping the 
first stimulation method; this applied to both DC and DRG stimulation. However, when 
comparing the T0 VAS scores with the T2 VAS scores, different VAS scores emerged in 7 of 
the 12 patients. This could imply that patients need a longer recovery time to prevent a 
carryover effect or that a response shift occurred during the first stimulation. As the VAS 
scores were compared before the start of a stimulation method and at the end of that 
specific stimulation method, the ascertainment of success cannot have been influenced 
by (events in) the washout period.
Regarding adverse events, as 2 different stimulation methods were implanted simulta-
neously, it was impossible to relate these events to either stimulation method. Of the 2 
patients with a possible infection, in one patient this necessitated removal of all the leads 
during the second surgical procedure. No wound complications were seen in the patient 
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group. As infection and wound complications are reported with either neurostimulation 
treatment (23), this did not differ in the present patient group.
All surgical procedures were performed by the same qualified physician (F.J.P.M.H.). 
The first surgical procedure was undoubtedly intense for patients, because 2 different 
stimulation methods were implanted simultaneously. Patients later reported that espe-
cially placement of the 2 DRG leads was more painful than placement of the single DC 
lead, which always took place first during the procedure. Also, for the physician, these 
procedures took longer, implying a potentially higher risk of infection and/or contamina-
tion (24).
A possible limitation of the present study was the lack of blinding; future studies should 
aim to find a more controlled, blinded way of comparing the 2 neurostimulation methods 
using a crossover design. Monitoring patients’ preference of stimulation method only im-
mediately after the trial period can also be considered as a limitation of the present study. 
After all, patients can change their mind over time. So the results at trial end cannot be 
generalized to the long term.
ConCluSion
To our knowledge, this is the first study to explore preferences for DC or DRG stimulation 
in patients with CRPS confined to the knee. The results show a preference for DRG stimula-
tion over DC stimulation, because DRG stimulation can be more specific for the painful 
area and is independent of the body position, and patients appreciated the absence of 
stimulation vibrations. It is not possible to generalize the results of this study to other CRPS 
locations (the foot or the hand). Nevertheless, we recommend that physicians consider 
DRG stimulation, rather than DC stimulation, in case of intractable CRPS confined to the 
knee. Follow-up data from this study are currently being processed.
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Letter to the editor
lEttER to thE EditoR
CRPS knee: how frequently encountered in differential diagnosis of knee pain?
to the Editor:
We have read with great interest the paper by van Bussel et al. recently published in Pain 
Practice (1). I wish to congratulate the authors for their valuable contributions.
In the article, 12 patients who had complex regional pain syndrome (CRPS) confined to the 
knee were included. Although reports have been published involving primarily the knee 
after total knee arthroplasty, the incidence of CRPS of the knee following trauma or other-
wise is not well appreciated (2, 3). We would have appreciated the authors mentioning the 
presence or absence of any inciting event for the development CRPS of the knee in these 
12 patients, which could help better diagnose and manage patients with CRPS of the knee.
Further, conditions affecting the knee frequently do not present with the classic combina-
tion of signs and symptoms seen in the upper extremity (4, 5). Did all 12 of the patients 
fully meet Budapest diagnostic criteria or was any working hypothesis of CRPS made in 
any patient on clinical grounds after ruling out other conditions? Commentary on this by 
the authors might have helped in reducing the wide discrepancy in interpretation of the 
signs and symptoms necessary to make the diagnosis of CRPS.
Also, since CRPS confined to the knee is infrequently encountered in the differential di-
agnosis of knee pain (6), we would have preferred that the authors share the time frame 
during which this particular study was conducted.
Thank you.
Aakanksha Aggarwal, MD and Anil Agarwal, MD, MNAMS, FICA, FIAPM
Department of Anaesthesiology, Sanjay Gandhi Post Graduate
Institute of Medical Sciences, Lucknow, India
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RESPonSE to thE lEttER to thE EditoR
dear Editor,
We totally agree with the statement of the authors of the letter to the editor that “the inci-
dence of CRPS knee following trauma or otherwise is not well appreciated.” We would like 
to refer to our earlier published paper in which we concluded that the scientiﬁc literature 
does report cases of complex regional pain syndrome (CRPS) type I of only the knee(s). 
Our recommendation was to consider CRPS conﬁned to the knee as a medical entity and 
therefore to include CRPS of only the knee(s) in future research on the etiological mecha-
nisms of and optimal treatment for CRPS (7).
The authors of the letter to the editor stated that “we would have appreciated if presence 
or absence of any inciting event for the development CRPS knee in these 12 patients could 
be mentioned, which could be helpful in a better diagnosis and management....” This is 
a good addition, and we certainly want to provide this information. Within the group of 
12 patients who all ﬁnished the trial period, the following causes of the knee CRPS were 
given: 7 patients had undergone (arthroscopic) surgery or an arthroscopy, 4 patients 
had a trauma of the knee (2 had a luxation of the patella and 2 patients had fallen on 
the speciﬁc knee), and 1 patient had a fracture of the tibia plateau. The surgical causes 
of CRPS conﬁned to the knee are in line with one of our earlier reports concerning CRPS 
conﬁned to the knee (7).
Another thing stated by the authors of the letter to the editor was “further, conditions 
affecting the knee frequently do not present with the classic combination of signs and 
symptoms seen in the upper extremity (3, 4).” We have studied presentation of CRPS 
conﬁned to the knee in an earlier study (8). Our conclusion was that the variation in terms 
of symptoms and signs of CRPS conﬁned to the knee compared to CRPS of the ankle/foot 
is limited. And the phenotypes of CRPS conﬁned to the knee and CRPS of the ankle/foot 
seem to be comparable, but not identical. This can be a reason why CRPS in patients with 
pain of the knee that is disproportionate to the initial trauma is sometimes not recognized. 
Nevertheless, the International Association for the Study of Pain (IASP) clinical Budapest 
diagnostic criteria can and should be used to diagnose CRPS conﬁned to the knee.
A further question raised by the authors of the letter to the editor was “... did all of the 12 
patients fully meet Budapest diagnostic criteria or any working hypothesis of CRPS...?” 
We can answer this question with “yes.” All of the patients included in this study fully met 
the IASP clinical Budapest diagnostic criteria, as this was one criterion for participation 
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in the study. All inclusion and exclusion criteria were described in Table 1 of the original 
manuscript.
The last question of the authors was “... could share with us the time frame during which 
this particular study was conducted?” Patients who were included in the study had a diag-
nosis of CRPS for over 1 year, as this was one of the inclusion criteria for participation. The 
total length of the study was 1 year per patient; this includes the follow up of 12 months 
after neurostimulation implantation. The time between the ﬁrst patients being included 
and the last patient scheduled for 12 months’ follow-up was approximately 3 years.
We agree with the authors of the letter to the editor that “CRPS conﬁned to the knee is 
infrequently encountered in differential diagnosis of knee pain (6).” We hope that our 
previous and current work, the letter to the editor, and our answers will change this and 
be of help for those patients with a serious, invalidating problem that is denied too often.
On behalf of all the authors, I thank the editor for the opportunity to comment on the 
questions raised and the notes made by the authors of this manuscript. We hope we have 
added more understanding of our paper with these answers.
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CoMPlEX REgional Pain SyndRoME (CRPS) ConfinEd to thE KnEE: to BE oR 
not to BE?
Over the years, complex regional pain syndrome (CRPS) has been relabelled several times. 
Before the term CRPS was adapted for this disease, algodystrophy and reflex sympathetic 
dystrophy (RSD) were most commonly used. ‘Complex’ refers to the clinical symp toms 
such as pain and sensory and motor abnormalities, and ‘regional’ to the distribution of 
the signs and symptoms. This distribution is often glove or stocking shaped and not within 
a specific nerve distribution or a dermatome. ‘Pain’ is the main symptom of the disease 
and is disproportionate to the intensity of the initial trauma (1). CRPS affecting a hand or a 
foot has been widely accepted and discussed.
A group of patients was seen in the Center for Pain Medicine, Erasmus University Medical 
Center, with painful complaints confined to the knee. Our motivation to perform the stud-
ies mentioned below and to write this thesis is to determine whether these complaints 
meet the diagnostic criteria for CRPS. The main objective is to establish whether CRPS 
confined to the knee is a legitimate diagnosis and, if so, to increase the knowledge of its 
development. We hope to disseminate the knowledge of this diagnosis among physicians 
and thus to facilitate the recognition of patients’ complaints as CRPS confined to the knee. 
We also want to offer patients a treatment for this very disabling and painful condition. In 
this chapter, we discuss the results of our studies and make a recommendation for future 
research.
diSCuSSion of thE RESultS
Regarding the legitimacy of the diagnosis CRPS confined to the knee, we performed a 
systematic review to answer this question: Are there descriptions in the medical literature 
of CRPS affecting the knee(s) that is diagnosed according to the criteria used at the time 
of publication (see Chapter 2)? We concluded that CRPS affecting solely the knee(s) has 
actually been described before, and more than 20% of the reported cases would meet 
the current Budapest diagnostic criteria set. In addition, we summarised the aetiology 
and possible treatment of CRPS confined to the knee. A total of 44% of the cases had 
(arthroscopic) knee surgery as the inciting event (2-4). When considering the differential 
diagnosis of CRPS confined to the knee, however, inflammatory arthritis, cellulitis, osteo-
myelitis, deep vein thrombosis, vascular disorders, entrapment neuropathies and malig-
nancy should always be considered (5). Furthermore, post-surgical pain (if development 
started after a surgical procedure) and infrapatellar saphenous neuralgia (which causes 
characteristically neuropathic pain) should also be considered as a differential diagnosis 
(6).
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Having assumed that CRPS confined to the knee is a legitimate diagnosis, we compared 
the phenotypes at the time of diagnosis of patients with CRPS of the knee to those of 
patients diagnosed with CRPS of the ankle/foot. In this retrospective study, which is 
described in Chapter 3, we found a significant difference in the duration of complaints 
before patients received a diagnosis of CRPS (P = 0.02). Patients with CRPS of the knee 
suffered longer than patients with CRPS of the ankle/foot before being correctly diag-
nosed. This delay in diagnosing CRPS confined to the knee was not a new finding. Earlier 
reports had described averages delay of 29 months, 26 months and 11.2 months (3, 5, 
8). All patients in our study mentioned severe, continuing pain at the time of diagnosis. 
At diagnosis, patient reports of hyperesthesia, hyperalgesia, decreased range of motion 
and dystonia were statistically significantly more common in the ankle/foot group than 
in the knee group. In terms of signs, hypoesthesia, hyperalgesia, color asymmetry and 
sweating asymmetry were observed statistically significantly more often in the ankle/
foot group. Because of the longer duration before diagnosing CRPS confined to the knee, 
and the fact that CRPS changes over time, we performed a post hoc pairwise matching 
analysis excluding this difference in duration. This factor could, after all, have impaired 
internal validity of our research. When the difference in time to diagnosis was controlled 
for, however, the differences in the proportions of patients suffering from the symptoms 
and signs listed above were unchanged. These differences might be due to (not having 
corrected for) multiple testing, but for example, dystonia of the knee is uncommon and 
difficult to examine, because decreased range of motion in the knee will already influence 
flexion and extension. For the knee CRPS group, surgery or arthroscopy turned out to be 
the most common initiating event. In contrast, for the ankle/foot group, a fracture of the 
lower leg was the most frequently reported precipitating event. Based on our results, we 
concluded that although the variation between the phenotypes of knee CRPS and ankle/
foot CRPS is small, the two conditions are not identical.
Having found phenotypical variation at the time of diagnosis between these two condi-
tions, we investigated the clinical course of CRPS confined to the knee. In addition, we 
compared the clinical course between pairwise-matched patients in the two groups. This 
work is described in Chapter 4. Spontaneous resolution (without having received any kind 
of treatment) did not occur in the group of patients with CRPS of the knee, although such 
resolution has been described for CRPS of more distal locations (7, 8). The self-reported 
recovery rate (among those having received treatment) was 16% in our CRPS confined to 
the knee group, which contrasts with a recovery rate of 29% in a CRPS of the ankle/foot 
group in an earlier study reported by de Mos et al (9). Based on the pairwise matching 
analysis across the groups, we concluded that symptoms in the group with CRPS confined 
to the knee were more stable over time, although recovery was less common. Both of these 
differences may be because the delay in recognition of CRPS in this group may result in 
aggravation or stabilization of the signs and symptoms before correct treatment is started 
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(10). The health-related quality of life experienced by patients with CRPS confined to the 
knee turned out to be comparable to that of patients with CRPS in more distal locations. 
Also, we found a work status change due to CRPS of 82% in the CRPS of the knee patient 
group, which is in line with the 72% work status change due to CRPS of other locations 
described by Kemler et al (11). Thus, the adverse impact on working status and health-
related quality of life of CRPS confined to the knee seems to be comparable to that of CRPS 
of more distal locations. This despite the fact that CRPS of the knee seems to have a less 
favorable clinical course than CRPS of more distal locations in terms of presentation of 
symptoms and signs over time.
The literature describes various treatment strategies, with various outcomes (12, 13). 
In our department, we have seen patients with CRPS confined to the knee who failed to 
respond to all treatments. The failure to respond to treatment in this patient group has 
also been described by Miller (14). So, the challenges of finding a successful therapy for 
CRPS confined to the knee seem to match those encountered in the search for a successful 
therapy for CRPS of more distal locations. This gave rise to our next studies. Spinal cord 
stimulation (SCS) is an accepted and effective treatment for specific types of chronic pain, 
and CRPS is the second most common indication (15). Because dorsal root ganglion (DRG) 
stimulation became available, and provided positive results in patients with CRPS of the 
lower extremities (16), we hypothesized that this type of stimulation could be an option for 
patients with CRPS confined to the knee. In Chapter 5, we described a patient diagnosed 
with CRPS confined to the knee that we successfully treated with DRG stimulation. After 
the implantation of three DRG leads at the lumbar spinal level, the entire painful area at 
the knee was covered with stimulation vibrations and the patient reported a substantial 
decrease in pain intensity. We considered these results to be encouraging and the DRG to 
be a potential new target for reducing neuroplastic pain due to CRPS confined to the knee. 
Because we have seen both the successes and the failures of SCS in patients with CRPS 
confined to the knee, we performed a prospective study comparing the two methods of 
neurostimulation, that is, SCS and DRG stimulation, to determine patients’ preference. 
This study is reported in Chapter 6. A total of 14 patients were included, of whom 12 fin-
ished the trial period, and all received an implantable pulse generator (IPG) because of a 
successful trial. Ten patients (83.3%) preferred DRG stimulation, and two preferred SCS 
(P = 0.04). The pain reduction, assessed on a visual analogue scale (VAS), turned out to 
be comparable between SCS and DRG stimulation, so patient preferences were not solely 
based on pain relief experienced. This is in line with results presented by others (17). Our 
study confirms that SCS tends to be nonspecific and has more positional side effects (18). 
These nonspecific stimulation vibrations (covering an area bigger than solely the painful 
area) and positional side effects were reasons patients cited in expressing a preference for 
DRG stimulation over SCS. Pain not restricted to a specific dermatome could be targeted 
by DRG stimulation, as we saw in the first patient we treated. DRG stimulation can relieve 
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pain in the affected area without the patient’s experiencing stimulation vibrations, which 
was one of the main reasons patients in our group preferred DRG over SCS. In addition, 
DRG stimulation turned out to be more user-friendly than SCS, as patients had to adjust 
the SCS intensity multiple times a day. Also, DRG stimulation could be superior to SCS in 
treating the dystonia component of CRPS. This is an interesting finding for patients with 
CRPS confined to the knee, as dystonia of the knee results in a completely non-usable 
limb.
All included patients mentioned the fact that the implantation of the DRG leads was 
much more painful than the implantation of the SCS lead. Also, we found it impossible to 
implant the DRG leads in one patient, possibly due to degeneration of the spine, which is 
something the physician should be aware of when choosing DRG stimulation as a potential 
treatment. Overall, DRG stimulation was preferred over SCS by the majority of the patients 
with CRPS confined to the knee. We recommend that physicians consider DRG stimula-
tion, rather than SCS, as a potential treatment for patients with chronic neuroplastic pain 
due to CRPS confined to the knee. A letter to the editor concerning this prospective study 
and our response to the letter are presented in Chapter 7. The authors of the letter posed 
pertinent questions and provided relevant comments, to which we replied.
in ConCluSion
Having applied the currently recommended IASP clinical Budapest diagnostic criteria to 
patients with signs and symptoms of CRPS at the knee, we can state that CRPS confined 
to the knee is a legitimate diagnosis. This means that the knee should be considered a 
location in which CRPS can develop. Surgery is the most common preceding event related 
to this type of CRPS.
We hope the research described in this thesis will aid physicians in recognising CRPS of 
the knee(s) as a legitimate diagnosis, so that these patients will be better understood by 
their physicians.
The phenotypes of symptoms and signs of CRPS confined to the knee and those of 
CRPS of the ankle/foot at the time of diagnosis are not identical, although their variation 
is limited. Considering the location of the CRPS, some significant differences are under-
standable, although some of the variation may be due to a delay in diagnosing.
The clinical picture of CRPS confined to the knee is more stable over time, and thus has 
a less favourable clinical course than CRPS of other, more distal locations. The effects of 
this include an adverse impact on work status and health-related quality of life for these 
patients.
Neurostimulation should be considered as a potential treatment for patients with CRPS 
confined to the knee. We have found a patient preference for DRG stimulation over SCS, 
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although both neurostimulation methods gave equal pain reduction. Thus, physicians 
should not measure their treatment success only in terms of pain reduction.
RECoMMEndationS foR futuRE RESEaRCh
CRPS confined to the knee should be included among CRPS locations in all research into 
the condition. Much research has been conducted on the use of vitamin C as a preventative 
to the development of CRPS after wrist, hand, ankle and foot surgery. High-level evidence 
has been found supporting perioperative supplementation of vitamin C of 1g/d for 50 days 
for prevention of CRPS (19). As this thesis has shown, most cases of CRPS confined to the 
knee developed after (arthroscopic) knee surgery. This suggests we should consider the 
use of vitamin C supplementation during the perioperative period in patients who will 
undergo knee surgery.
Because the development of CRPS confined to the knee primarily occurs after surgery, 
there is a need to distinguish patients with post-surgical pain from patients with CRPS. 
Post-surgical pain is labelled as pain for at least 3–6 months after surgery that normally 
stabilises within these months and is regularly described in patients who underwent a 
total knee arthroplasty (20). CRPS is characterized by a continuing pain that is dispropor-
tionate in time or degree to the usual course of pain after trauma or another lesion. The 
pain is regional (i.e., not in a specific nerve territory or dermatome) and usually has a distal 
predominance of abnormal sensory, motor, sudomotor, vasomotor/edema and/or trophic 
findings. The syndrome shows variable progression over time. The difference between 
post-surgical pain and CRPS is the ongoing autoinflammation, which is not seen in post-
surgical pain, but actually is the distinguishing pathophysiologic characteristic phenom-
enon of especially acute CRPS. Also, patients with post-surgical pain of the knee describe 
primarily sensory and/or sudomotor complaints and, thus, do not meet the Budapest 
criteria to be diagnosed with CRPS (21). If the autoinflammation diminishes over time in 
CRPS, and the clinical picture is mainly based on what was damaged during the active 
inflammatory stage, it can become very challenging to distinguish between post-surgical 
pain and CRPS. Whenever an orthopaedic or trauma surgeon has doubts concerning the 
diagnosis and/or treatment in these cases, it is advisable that patients be referred to a pain 
specialist, given the necessity for a different therapeutic strategy.
The inter-individual variations in presentation of CRPS represent the heterogeneity of 
the underlying mechanisms, and an increasing amount of evidence is being collected 
towards a mechanism-based treatment for CRPS (1, 22). We recommend continuing re-
search into understanding the pathophysiology of CRPS and identifying the best therapy 
for patients, preferably mechanism-based therapy.
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Recently Bharwani et al. have shown that plasma levels of the soluble interleukin-2 
receptor (sIL-2R) are elevated in CRPS. The receptor reflects the activity of T-cells and, 
hence, the presence of an inflammatory process (23). This finding can guide physicians in 
distinguishing post-surgical pain from CRPS and in their treatment algorithm.
As shown in this thesis, neurostimulation should be considered as a treatment option 
for CRPS confined to the knee. Due to reimbursement policies, neurostimulation is used 
as a last resort for patients in whom more conservative treatment has failed. Using this 
treatment as a last resort is a disputable approach. First, we know by experience that these 
patients in particular are quite therapy-resistant to more conventional treatments. This 
calls into question the wisdom of having to exhaust more conservative treatments before 
moving to neurostimulation. Second, Gravius et al. recently performed a preliminary study 
to evaluate the impact of DRG stimulation on inflammatory markers in serum and saliva 
in patients with CRPS and matched controls. They found a significant decrease in serum 
anti-inflammatory interleukine-10 (IL-10), which had been elevated at baseline, 3 months 
after DRG stimulation in the CRPS group. This suggests a diminution of the ongoing inflam-
matory process known to occur in CRPS (24). This finding supports the consideration of 
applying neurostimulation therapy earlier in the treatment algorithm for CRPS confined 
to the knee.
We are aware of the fact that the diagnosis of CRPS confined to the knee is rare, but it 
has great consequences for the patients who develop it, and they should be diagnosed 
correctly and treated as quickly as possible. CRPS should be considered as a multidimen-
sional disease requiring an interdisciplinary approach, including psychological care (25). 
Thus, the answer to our ‘to be or not to be?’ question at the start of this chapter about 
CRPS confined to the knee must be ‘to be!’
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Summary
SuMMaRy
Chapter 1
The general introduction describes the rationale for this thesis. CRPS confined to the 
knee is an unrecognized location for CRPS. Due to this unfamiliarity, it typically takes 
considerable time before patients with this condition receive the right treatment for their 
complaints. In gathering more information about this specific location of CRPS, we hope 
to minimize this delay. Therefore, we explored the literature, performed several studies to 
investigate the clinical picture and the course of the disease, and conducted a clinical trial 
concerning the possibility of neuromodulation treatment.
Chapter 2
A systematic literature research revealed 31 articles concerning CRPS of only the knee(s) 
compromising a total of 368 patients. Most of these patients were diagnosed based on 
their clinical picture, and we determined that more than 20% of them would meet the 
currently recommended Budapest criteria. Several authors used lumbar sympathetic 
blockades and radiographs/bone scans to confirm whether a patient should be diagnosed 
with CRPS. This is in contrast to the currently used method of diagnosing CRPS purely 
based on the clinical picture. An (arthroscopic) surgery or arthroscopy of the knee ap-
peared to be the main inciting factor for development of CRPS, and the ideal treatment is 
yet to be found.
Chapter 3
To gain more information about the clinical features of CRPS confined to the knee, a ret-
rospective comparison was made between CRPS of the knee and CRPS of the ankle/foot 
at the time of diagnosis. We discovered that patients with CRPS confined to the knee had 
a significantly longer duration of their complaints before diagnosis than did patients with 
CRPS of the ankle/foot. Additionally, we found some significant differences regarding four 
symptoms and four signs, which probably can be explained by the difference in location of 
the CRPS. These findings indicate that the phenotypic variation in terms of symptoms and 
signs of CRPS confined to the knee compared to CRPS of the ankle/foot is limited, but the 
phenotypes are not identical.
Chapter 4
No earlier reports are known of the clinical course and impact of CRPS confined to the 
knee.We asked a total of 32 patients diagnosed with CRPS confined to the knee to report 
their past and current CRPS symptoms, work status and quality of life. Their mean follow-
up time since having received a CRPS diagnosis was 11.5 years, and their recovery rate was 
only 16%. The work status of most of the patients changed due to the diagnosis, and 91% 
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of the patients implied that pain in some way interfered in their lives. We also compared 
the clinical picture in terms of symptoms and signs of this group of patients with that of a 
group of patients with CRPS of more distal locations; patients with CRPS confined to the 
knee exhibited less change over the course of time.
Chapter 5
The dorsal root ganglion plays a pivotal role in the development and persistence of chronic 
pain and stimulation of this structure can be an effective and safe treatment for pain. Here, 
we describe the first patient diagnosed with intractable pain due to CRPS confined to the 
knee to be successfully treated with dorsal root ganglion stimulation.
Chapter 6
In this chapter, we present the results of our prospective, crossover, cohort study compar-
ing two methods of neurostimulation (dorsal root ganglion and spinal cord stimulation). 
The aim of the study was to explore patients’ preference in neurostimulation treatment 
of their chronic pain due to CRPS confined to the knee. A total of 12 patients finished 
the trial period, and the results show that the probability of a preference for one of the 
neurostimulation treatments significantly deviates from chance in favor of DRG stimula-
tion. Therefore, we recommend that physicians consider DRG stimulation in cases of 
intractable CRPS confined to the knee.
Chapter 7
Relevant questions and notes were made by two authors concerning our prospective 
study. They wrote a letter to the editor of the journal in which our study was published, 
and we had the opportunity to respond to this letter. The letter and our response are 
included in this chapter.
Chapter 8
Our general discussion in this chapter describes the current knowledge of CRPS confined 
to the knee and we summarize and comment on the findings of the several studies we 
conducted.. CRPS confined to the knee is a little known condition, but physicians should 
consider this diagnosis for patients with chronic pain of the knee, disproportionate to the 
event, that does not respond to treatment. CRPS is still a medical condition that is only 
partially understood, and future research on the etiological mechanisms should include 
CRPS confined to the knee.
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hoofdstuk 1
Het ontwikkelen van CRPS in de knie komt niet vaak voor. Mogelijk doordat deze locatie 
onbekend is onder artsen, lopen de patiënten een vertraging op met het krijgen van hun 
diagnose en daar aan gekoppelde behandelingen. Door meer kennis over het ontwikkelen 
van CRPS in de knie te verkrijgen, hopen we dat deze vertraging in de toekomst minder 
voor zal komen. Om dit voor elkaar te krijgen hebben we de huidige literatuur onderzocht, 
onderzoeken uitgezet naar het klinisch beeld van CRPS van de knie (ten tijde van de di-
agnose en na verloop van tijd) en hebben we een onderzoek gestart naar een mogelijke 
behandeling met neurostimulatie.
hoofdstuk 2
Voor het verzamelen van al bekende literatuur over CRPS van de knie hebben we op 
systematische wijze gezocht, en vonden we 31 artikelen die een totaal van 368 patiënten 
beschrijven. De meeste van deze patiënten waren gediagnosticeerd met CRPS van de knie 
op basis van het klinisch beeld, en retrospectief blijkt 20% te voldoen aan de Budapest 
criteria set. Ook blijken in het verleden invasieve methoden en radiologische bevestiging 
te zijn gebruikt voor het stellen van de diagnose CRPS, dit in tegenstelling tot de huidige 
manier van diagnose stellen. Artroscopische chirurgie of een artroscopie van de knie bleek 
de meest genoemde oorzaak van de CRPS. Meerdere vormen van behandelingen zijn ge-
bruikt, maar de juiste/beste behandeling moet nog gevonden worden.
hoofdstuk 3
Om meer informatie te verkrijgen over het klinische beeld van CRPS van de knie ten tijde 
van de diagnose hebben we een retrospectieve vergelijking gemaakt tussen deze locatie 
en CRPS van de voet/enkel. Patiënten gediagnosticeerd met CRPS van de knie bleken 
significant langer klachten te hebben voor het krijgen van de diagnose in vergelijking met 
patiënten met CRPS van de voet/enkel. Hiernaast vonden we ook een significant verschil 
bij een aantal klachten dat mogelijk verklaard kan worden door de desbetreffende locatie 
van de CRPS. Deze bevindingen indiceren dat de fenotypische variatie van klinische ken-
merken van CRPS van de knie en CRPS van de voet/enkel ten tijde van de diagnose beperkt 
is, maar dat de fenotypes niet identiek zijn.
hoofdstuk 4
Er is nog niets bekend in de literatuur over het klinische beeld en de impact van CRPS van 
de knie over het verloop van tijd. We vroegen aan 32 patiënten of ze een aantal vragen 
wilden beantwoorden over de klachten ten tijde van de diagnose en de huidige klachten, 
over hun werkstatus en over de kwaliteit van leven. Het bleek dat maar 16% volledig 
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hersteld was na een gemiddelde CRPS duur van 11.5 jaar. Hiernaast was de werkstatus 
van de meeste patiënten veranderd door de diagnose en 91% van de patiënten gaf aan dat 
de pijn die ze ervaarden voor last zorgde in hun leven. Een vergelijking van het klinische 
beeld tussen CRPS van de knie en CRPS van andere locaties liet zien dat CRPS van de knie 
significant minder verandering doormaakt in het verloop van de tijd.
hoofdstuk 5
Van het spinale ganglion is inmiddels bekend dat het een zeer belangrijke rol speelt bij 
de ontwikkeling van en het behouden van chronische pijn. Stimulatie van het spinale 
ganglion middels neurostimulatie blijkt een veilige en effectieve manier van behandelen 
van de pijnklachten. In dit hoofdstuk beschrijven we een patiënt met CRPS van de knie, die 
succesvol behandeld is met behulp van neurostimulatie op het spinale ganglion.
hoofdstuk 6
Dit hoofdstuk beschrijft de resultaten van de proefperiode van ons prospectieve onder-
zoek naar twee manieren van neurostimulatie bij patiënten gediagnosticeerd met CRPS 
van de knie. We vergeleken de stimulatie van het spinale ganglion met de stimulatie van 
de dorsale hoorn. Het doel van het onderzoek was om achter de voorkeur van manier 
van stimuleren bij deze patiënten te komen. Twaalf patiënten hebben uiteindelijk de 
proefperiode volledig doorlopen en het bleek dat stimulatie van het spinale ganglion de 
voorkeur had over stimulatie van de dorsale hoorn. Daarom raden we artsen dan ook aan 
om spinale ganglion stimulatie te overwegen voor een patiënt met onbehandelbare CRPS 
van de knie.
hoofdstuk 7
Terechte vragen en opmerkingen over het prospectieve onderzoek zijn geplaatst door 
twee lezers in een brief aan de editor. In dit hoofdstuk zijn de brief aan de editor en de 
reactie die we hierop schreven te vinden.
hoofdstuk 8
In de discussie wordt de huidige kennis over CRPS van de knie besproken. Hiernaast wor-
den alle resultaten van de onderzoeken die uitgevoerd zijn in het kader van dit proefschrift 
samengevat en becommentarieerd. CRPS van de knie is een diagnose die nog niet vaak 
gesteld wordt, en mogelijk weinig voorkomt, maar heeft wel een potentieel lange ziek-
telast. Zodoende raden we artsen aan om differentiaal diagnostisch te denken aan CRPS 
bij een patiënt met onbehandelbare pijnklachten van de knie. Tot op heden is CRPS nog 
maar deels verklaard en in toekomstig onderzoek naar de etiologie van CRPS zou de knie 
als mogelijke locatie ook moeten worden opgenomen.

